| Year |
Citation |
Score |
| 2023 |
Harada T, Kikushige Y, Miyamoto T, Uno K, Niiro H, Kawakami A, Koga T, Akashi K, Yoshizaki K. Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease. Nature Communications. 14: 6959. PMID 37907518 DOI: 10.1038/s41467-023-42718-0 |
0.319 |
|
| 2023 |
Yoshimoto G, Miyamoto T. [Maintenance therapy after allogeneic hematopoietic stem cell transplantation]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 64: 533-546. PMID 37407479 DOI: 10.11406/rinketsu.64.533 |
0.352 |
|
| 2022 |
Taniguchi S, Utsumi S, Kochi Y, Taya Y, Mori Y, Semba YI, Sugio T, Miyawaki K, Kikushige Y, Kunisaki Y, Yoshimoto G, Numata A, Kato K, Uchida N, Maeda T, ... Miyamoto T, et al. Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation. International Journal of Hematology. PMID 36136227 DOI: 10.1007/s12185-022-03458-x |
0.409 |
|
| 2022 |
Utsunomiya A, Tokunaga M, Nakano N, Fujiwara H, Miyamoto T, Ogata M, Miyazaki Y, Ishitsuka K, Sakaida E, Taji H, Wakayama T, Ichinohe T, Fukuda T, Atsuta Y, Kato K, et al. Long-term follow-up of patients with ATL after autologous stem cell transplantation. Bone Marrow Transplantation. 57: 323-325. PMID 35066568 DOI: 10.1038/s41409-021-01412-9 |
0.336 |
|
| 2022 |
Fuji S, Hirakawa T, Takano K, Doki N, Sawa M, Kanda Y, Uchida N, Ara T, Miyamoto T, Eto T, Matsuoka KI, Kawakita T, Ozawa Y, Katayama Y, Onizuka M, et al. Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group. Bone Marrow Transplantation. PMID 35039621 DOI: 10.1038/s41409-022-01569-x |
0.353 |
|
| 2021 |
Fuchida SI, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, et al. Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. PMID 34774818 DOI: 10.1016/j.jtct.2021.10.021 |
0.305 |
|
| 2021 |
Kuno M, Yamasaki S, Fujii N, Ishida Y, Fukuda T, Kataoka K, Uchida N, Katayama Y, Sato M, Onai D, Miyamoto T, Ota S, Yoshioka S, Ara T, Hangaishi A, et al. Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation. American Journal of Hematology. PMID 34738245 DOI: 10.1002/ajh.26401 |
0.338 |
|
| 2021 |
Suetsugu K, Muraki S, Fukumoto J, Matsukane R, Mori Y, Hirota T, Miyamoto T, Egashira N, Akashi K, Ieiri I. Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study. Drugs in R&D. 21: 419-429. PMID 34655050 DOI: 10.1007/s40268-021-00365-0 |
0.333 |
|
| 2021 |
Kobayashi S, Kanda Y, Konuma T, Inamoto Y, Matsumoto K, Uchida N, Ikegame K, Miyamoto T, Doki N, Nakamae H, Katayama Y, Takahashi S, Shiratori S, Saito S, Kawakita T, et al. Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation. Bone Marrow Transplantation. PMID 34625663 DOI: 10.1038/s41409-021-01485-6 |
0.374 |
|
| 2021 |
Fuji S, Hakoda A, Kanda J, Murata M, Terakura S, Inamoto Y, Uchida N, Toya T, Eto T, Nakamae H, Ikegame K, Tanaka M, Kawakita T, Kondo T, Miyamoto T, et al. Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplantation. PMID 34480119 DOI: 10.1038/s41409-021-01443-2 |
0.334 |
|
| 2021 |
Yoshimoto G, Mori Y, Kato K, Odawara J, Kuriyama T, Ueno T, Obara T, Yurino A, Yoshida S, Ogawa R, Ohno Y, Iwasaki H, Eto T, Akashi K, Miyamoto T. Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation. Leukemia & Lymphoma. 1-10. PMID 34159882 DOI: 10.1080/10428194.2021.1941937 |
0.356 |
|
| 2021 |
Murata M, Terakura S, Wake A, Miyao K, Ikegame K, Uchida N, Kataoka K, Miyamoto T, Onizuka M, Eto T, Doki N, Ota S, Sato M, Hashii Y, Ichinohe T, et al. Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence. Bone Marrow Transplantation. PMID 33976381 DOI: 10.1038/s41409-021-01304-y |
0.321 |
|
| 2021 |
Fujimoto A, Anzai T, Fukuda T, Uchida N, Ohta T, Mori T, Sawa M, Yoshioka S, Miyamoto T, Uchiyama H, Katayama Y, Matsuoka KI, Shiratori S, Nakazawa H, Kanda J, et al. Impact of event-free survival status after stem cell transplantation on subsequent survival of patients with lymphoma. Blood Advances. 5: 1412-1424. PMID 33666656 DOI: 10.1182/bloodadvances.2020003735 |
0.35 |
|
| 2020 |
Mori Y, Sasaki K, Ito Y, Kuriyama T, Ueno T, Kadowaki M, Aoki T, Sugio T, Yoshimoto G, Kato K, Maeda T, Nagafuji K, Akashi K, Miyamoto T. Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study. Annals of Hematology. PMID 33150464 DOI: 10.1007/s00277-020-04310-0 |
0.307 |
|
| 2020 |
Oya S, Morishige S, Ozawa H, Sasaki K, Semba Y, Yamasaki Y, Nakamura T, Aoyama K, Seki R, Mouri F, Osaki K, Miyamoto T, Maeda T, Nagafuji K. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion. International Journal of Hematology. PMID 32951102 DOI: 10.1007/S12185-020-03006-5 |
0.399 |
|
| 2020 |
Muranushi H, Shindo T, Hishizawa M, Tokunaga M, Wake A, Nakano N, Eto T, Hidaka M, Choi I, Miyamoto T, Uchida N, Moriuchi Y, Miyazaki Y, Fukuda T, Ichinohe T, et al. GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma. Bone Marrow Transplantation. PMID 32665675 DOI: 10.1038/S41409-020-00996-Y |
0.455 |
|
| 2020 |
Uchida N, Matsumoto K, Sakura T, Hidaka M, Miyamoto T, Eto T, Maeda Y, Murayama T, Fujishima N, Yoshimoto G, Morita K, Kishimoto J, Teshima T, Taniguchi S, Yamashita T, et al. Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies. International Journal of Hematology. PMID 32656637 DOI: 10.1007/S12185-020-02941-7 |
0.443 |
|
| 2020 |
Henzan H, Takase K, Kamimura T, Mori Y, Yoshimoto G, Iwasaki H, Nagafuji K, Ogawa R, Eto T, Uchida N, Fujisaki T, Kato K, Minami M, Kikushige Y, Akashi K, ... Miyamoto T, et al. Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. International Journal of Hematology. PMID 32524309 DOI: 10.1007/S12185-020-02911-Z |
0.331 |
|
| 2020 |
Kida M, Usuki K, Uchida N, Fukuda T, Katayama Y, Kondo T, Eto T, Matsuoka KI, Matsuhashi Y, Ota S, Sawa M, Miyamoto T, Ichinohe T, Kimura T, Atsuta Y, et al. Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in Japan. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32320746 DOI: 10.1016/J.Bbmt.2020.04.004 |
0.443 |
|
| 2020 |
Yuda J, Odawara J, Minami M, Muta T, Kohno K, Tanimoto K, Eto T, Shima T, Kikushige Y, Kato K, Takenaka K, Iwasaki H, Minami Y, Ohkawa Y, Akashi K, ... Miyamoto T, et al. TKIs induce alternative spliced BCR-ABL variant via inhibition of RNA polymerase Ⅱ on genomic BCR-ABL. Cancer Science. PMID 32314454 DOI: 10.1111/Cas.14424 |
0.319 |
|
| 2020 |
Yamasaki S, Yoshida S, Kato K, Choi I, Imamura Y, Kohno K, Henzan H, Tanimoto K, Ogawa R, Suehiro Y, Miyamoto T, Eto T, Ohshima K, Akashi K, Iwasaki H, et al. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma. International Journal of Hematology. PMID 32297159 DOI: 10.1007/S12185-020-02879-W |
0.454 |
|
| 2020 |
Tochigi T, Miyamoto T, Hatakeyama K, Sakoda T, Ishihara D, Irifune H, Shima T, Kato K, Maeda T, Ito T, Handa H, Akashi K, Kikushige Y. Aromatase is a novel neo-substrate of cereblon responsible for immunomodulatory drugs-induced thrombocytopenia. Blood. PMID 32219443 DOI: 10.1182/Blood.2019003749 |
0.3 |
|
| 2020 |
Jinnouchi F, Yamauchi T, Yurino A, Nunomura T, Nakano M, Iwamoto C, Obara T, Miyawaki K, Kikushige Y, Kato K, Maeda T, Miyamoto T, Baba E, Akashi K, Takenaka K. Establishment of a human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells. Blood. PMID 32206775 DOI: 10.1182/Blood.2019002194 |
0.378 |
|
| 2020 |
Oku S, Takeshita T, Futatsuki T, Kageyama S, Asakawa M, Mori Y, Miyamoto T, Hata J, Ninomiya T, Kashiwazaki H, Yamashita Y. Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of allogeneic hematopoietic stem cell transplantation. Plos Pathogens. 16: e1008348. PMID 32150591 DOI: 10.1371/Journal.Ppat.1008348 |
0.4 |
|
| 2020 |
Harada T, Kuriyama T, Nishida R, Yoshimoto G, Mori Y, Imanaga H, Ueno T, Odawara J, Hayashi M, Kato K, Takenaka K, Akashi K, Miyamoto T. Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. PMID 32146107 DOI: 10.1016/J.Jiac.2019.12.013 |
0.382 |
|
| 2020 |
Ishida S, Morikawa H, Watanabe H, Tsuji T, Sugio T, Mori Y, Miyamoto T, Masuda S, Akashi K, Egashira N. Increasing Diluent Volume Decreases Bendamustine-Induced Venous Irritation without Reducing the Therapeutic Efficacy. Biological & Pharmaceutical Bulletin. 43: 488-492. PMID 32115507 DOI: 10.1248/Bpb.B19-00826 |
0.325 |
|
| 2020 |
Mori T, Shiratori S, Suzumiya J, Kurokawa M, Shindo M, Naoyuki U, Katsuto T, Miyamoto T, Morishige S, Hirokawa M, Fukuda T, Atsuta Y, Suzuki R. Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome. Hematological Oncology. PMID 32011008 DOI: 10.1002/Hon.2719 |
0.466 |
|
| 2020 |
Mori Y, Choi I, Yoshimoto G, Muta T, Yamasaki S, Tanimoto K, Kamimura T, Iwasaki H, Ogawa R, Akashi K, Miyamoto T. Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma. International Journal of Hematology. PMID 31981096 DOI: 10.1007/S12185-020-02833-W |
0.338 |
|
| 2020 |
Kiyoi H, Morris JD, Oh I, Maeda Y, Minami H, Miyamoto T, Sakura T, Iida H, Tuglus CA, Chen Y, Dos Santos C, Kalabus J, Anderson A, Hata T, Nakashima Y, et al. Phase 1b/2 Study of Blinatumomab in Japanese Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia. Cancer Science. PMID 31971321 DOI: 10.1111/Cas.14322 |
0.361 |
|
| 2020 |
Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Ogata M, Sugio Y, Fukuda T, Uchida N, Ikegame K, Matsuoka KI, Shiratori S, Kondo T, Miyamoto T, Eto T, Ichinohe T, et al. Low incidence of post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab. Hematological Oncology. PMID 31953867 DOI: 10.1002/Hon.2714 |
0.47 |
|
| 2019 |
Yoshimitsu M, Fuji S, Utsunomiya A, Nakano N, Ito A, Ito Y, Miyamoto T, Suehiro Y, Kawakita T, Moriuchi Y, Nakamae H, Kanda Y, Ichinohe T, Fukuda T, Atsuta Y, et al. Outcomes of allogeneic hematopoietic stem cell transplantation for ATL with HTLV-1 antibody positive donors: Allo-HCT for ATL from HTLV-1 antibody positive donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31821886 DOI: 10.1016/J.Bbmt.2019.12.004 |
0.422 |
|
| 2019 |
Ogata M, Uchida N, Fukuda T, Ikegame K, Kamimura T, Onizuka M, Kato K, Kobayashi H, Sasahara Y, Sawa M, Sawada A, Hasegawa D, Masuko M, Miyamoto T, Okamoto S. Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplantation. PMID 31745253 DOI: 10.1038/S41409-019-0752-5 |
0.401 |
|
| 2019 |
Yoshida S, Ohno Y, Nagafuji K, Yoshimoto G, Sugio T, Kamimura T, Ohta T, Takase K, Henzan H, Muta T, Iwasaki H, Ogawa R, Eto T, Akashi K, Miyamoto T. Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation. Annals of Hematology. PMID 31628517 DOI: 10.1007/S00277-019-03801-Z |
0.356 |
|
| 2019 |
Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka KI, Miyamoto T, Iida H, Ikegame K, Fukuda T, Ichinohe T, et al. Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31618688 DOI: 10.1016/J.Bbmt.2019.10.004 |
0.419 |
|
| 2019 |
Yanada M, Takami A, Mizuno S, Mori J, Chou T, Usuki K, Uchiyama H, Amano I, Fujii S, Miyamoto T, Saito T, Kamimura T, Ichinohe T, Fukuda T, Okamoto S, et al. Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan. International Journal of Hematology. PMID 31612307 DOI: 10.1007/S12185-019-02759-Y |
0.458 |
|
| 2019 |
Nagafuji K, Matsumura I, Shimose T, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Kadowaki N, Ishikawa J, Imamura Y, Yamazaki H, Akashi K, Kanakura Y. Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt). International Journal of Hematology. PMID 31538327 DOI: 10.1007/S12185-019-02736-5 |
0.34 |
|
| 2019 |
Kawase T, Tanaka H, Kojima H, Uchida N, Ohashi K, Fukuda T, Ozawa Y, Ikegame K, Eto T, Mori T, Miyamoto T, Hidaka M, Shiratori S, Takanashi M, Atsuta Y, et al. Impact of high frequency HLA haplotypes on clinical cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31400501 DOI: 10.1016/J.Bbmt.2019.07.042 |
0.374 |
|
| 2019 |
Kodama T, Kochi Y, Nakai W, Mizuno H, Baba T, Habu K, Sawada N, Tsunoda H, Shima T, Miyawaki K, Kikushige Y, Mori Y, Miyamoto T, Maeda T, Akashi K. Anti-GPRC5D/CD3 bispecific T cell-redirecting antibody for the treatment of multiple myeloma. Molecular Cancer Therapeutics. PMID 31270154 DOI: 10.1158/1535-7163.Mct-18-1216 |
0.431 |
|
| 2019 |
Nagafuji K, Miyamoto T, Eto T, Ogawa R, Okumura H, Takase K, Kawano N, Miyazaki Y, Fujisaki T, Wake A, Ohno Y, Kurokawa T, Kamimura T, Takamatsu Y, Yokota S, et al. Prospective evaluation of Minimal Residual Disease (MRD) monitoring to Predict Prognosis of Adult Patients with Ph-negative ALL. European Journal of Haematology. PMID 31132205 DOI: 10.1111/Ejh.13268 |
0.407 |
|
| 2019 |
Suetsugu K, Mori Y, Yamamoto N, Shigematsu T, Miyamoto T, Egashira N, Akashi K, Masuda S. Impact of , and Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences. 20. PMID 31096684 DOI: 10.3390/Ijms20102413 |
0.399 |
|
| 2019 |
Aoki T, Kamimura T, Yoshida S, Mori Y, Kadowaki M, Kohno K, Ishihara D, Urata S, Sugio T, Kamezaki K, Kato K, Ito Y, Eto T, Akashi K, Miyamoto T. Safety and seropositivity after live attenuated vaccine in adult patients receiving hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30959161 DOI: 10.1016/J.Bbmt.2019.04.006 |
0.336 |
|
| 2019 |
Sunami K, Matsumoto M, Fuchida SI, Omoto E, Takamatsu H, Adachi Y, Choi I, Fujishima N, Kiguchi T, Miyamoto T, Maeda A, Suzumiya J, Yamamura R, Nagafuji K, Nakazato T, et al. Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12). International Journal of Clinical Oncology. PMID 30937622 DOI: 10.1007/S10147-019-01436-8 |
0.45 |
|
| 2019 |
Minami M, Matsushima T, Mori Y, Ishihara D, Jinnnouchi F, Takenaka K, Henzan T, Yoshimoto G, Numata A, Kato K, Maeda T, Miyamoto T, Akashi K. Successful rescue transplantation with desensitization procedure after primary graft failure due to donor-specific antibody. Bone Marrow Transplantation. PMID 30804490 DOI: 10.1038/S41409-019-0486-4 |
0.33 |
|
| 2019 |
Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, Miyazaki Y, Kanda J, et al. Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. American Journal of Hematology. PMID 30773707 DOI: 10.1002/Ajh.25438 |
0.459 |
|
| 2019 |
Ayano M, Tsukamoto H, Mitoma H, Kimoto Y, Akahoshi M, Arinobu Y, Miyamoto T, Horiuchi T, Niiro H, Nagafuji K, Harada M, Akashi K. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan. Arthritis Research & Therapy. 21: 30. PMID 30670057 DOI: 10.1186/S13075-019-1823-0 |
0.441 |
|
| 2019 |
Hayashi M, Kikushige Y, Harada T, Miyamoto T, Maeda T, Akashi K. Somatic Mutations Potentiating RAS-MAPK Signaling Confer Resistant Potential Against FLT3-Inhibitors to Acute Myelogenous Leukemia Blood. 134: 910-910. DOI: 10.1182/Blood-2019-130694 |
0.338 |
|
| 2019 |
Kikushige Y, Miyamoto T, Maeda T, Akashi K. Human Acute Leukemia Is Addicted to Branched-Chain Amino Acid Metabolism to Maintain Leukemia Stemness Blood. 134: 2516-2516. DOI: 10.1182/Blood-2019-129372 |
0.416 |
|
| 2019 |
Sakoda T, Kikushige Y, Harada T, Irifune H, Hayashi M, Yoshimoto G, Miyamoto T, Akashi K. Evaluation of TIM-3-Positive LSCs Post Allo-SCT Is a Highly Sensitive Strategy to Predict AML Relapses Blood. 134: 2702-2702. DOI: 10.1182/Blood-2019-127779 |
0.437 |
|
| 2019 |
Irifune H, Kochi Y, Hayashi M, Kikushige Y, Miyamoto T, Akashi K. Identification of GPAT1 As a Novel Therapeutic Target for Acute Leukemia By Inhibiting Leukemia Specific Metabolism Blood. 134: 1384-1384. DOI: 10.1182/Blood-2019-125661 |
0.384 |
|
| 2019 |
Kobayashi Y, Oh I, Miyamoto T, Lee W, Iida H, Minami H, Maeda Y, Jang JH, Yoon S, Yeh S, Tran Q, Morris J, Franklin JL, Chong K, Kiyoi H. Efficacy and Safety of Blinatumomab in Asian Adults with Relapsed/Refractory B-Precursor ALL Blood. 134: 5069-5069. DOI: 10.1182/Blood-2019-124582 |
0.314 |
|
| 2019 |
Muranushi H, Shindo T, Hishizawa M, Tokunaga M, Wake A, Nakano N, Eto T, Hidaka M, Choi I, Miyamoto T, Uchida N, Moriuchi Y, Miyazaki Y, Fukuda T, Ichinohe T, et al. Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm Blood. 134: 2008-2008. DOI: 10.1182/Blood-2019-123318 |
0.457 |
|
| 2019 |
Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Ogata M, Fukuda T, Uchida N, Ikegame K, Matsuoka K, Shiratori S, Kondo T, Miyamoto T, Ichinohe T, Kanda Y, Atsuta Y, et al. Post-Transplant Lymphoproliferative Disorder In Patients With Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation Hematological Oncology. 37: 261-262. DOI: 10.1002/Hon.70_2630 |
0.454 |
|
| 2018 |
Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, et al. HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome. Haematologica. PMID 30523056 DOI: 10.3324/Haematol.2018.204438 |
0.382 |
|
| 2018 |
Yamasaki S, Chihara D, Kim SW, Kawata T, Mizuta S, Ago H, Chou T, Yamane T, Uchiyama H, Oyake T, Miura K, Saito B, Taji H, Nakamae H, Miyamoto T, et al. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma. International Journal of Hematology. PMID 30430419 DOI: 10.1007/S12185-018-2560-X |
0.446 |
|
| 2018 |
Takamatsu H, Yamashita T, Kurahashi S, Saitoh T, Kondo T, Maeda T, Nakazawa H, Murata M, Narita T, Kuroda J, Hashimoto H, Kawamura K, Miyamoto T, Honda S, Ichinohe T, et al. Clinical implications of t(11;14) in patients with multiple myeloma undergoing autologous stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30423479 DOI: 10.1016/J.Bbmt.2018.11.003 |
0.348 |
|
| 2018 |
Uchida M, Nakamura T, Shima T, Yoshimoto G, Kato K, Hosohata K, Miyamoto T, Akashi K. Comparative Quantification of Chemotherapy-Induced Nausea and Emesis between the Common Terminology Criteria for Adverse Events and the Multinational Association of Supportive Care in Cancer Antiemesis Tool. Biological & Pharmaceutical Bulletin. 41: 1667-1671. PMID 30381666 DOI: 10.1248/Bpb.B18-00336 |
0.317 |
|
| 2018 |
Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M, et al. A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma. International Journal of Hematology. PMID 30284685 DOI: 10.1007/S12185-018-2543-Y |
0.361 |
|
| 2018 |
Yamasaki S, Yoshimoto G, Kohno K, Henzan H, Aoki T, Tanimoto K, Sugio Y, Muta T, Kamimura T, Ohno Y, Ogawa R, Eto T, Nagafuji K, Miyamoto T, Akashi K, et al. Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation. International Journal of Hematology. PMID 30251131 DOI: 10.1007/S12185-018-2538-8 |
0.406 |
|
| 2018 |
Sugio T, Miyawaki K, Kato K, Sasaki K, Yamada K, Iqbal J, Miyamoto T, Ohshima K, Maeda T, Miyoshi H, Akashi K. Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS. Blood Advances. 2: 2242-2252. PMID 30194138 DOI: 10.1182/Bloodadvances.2018018754 |
0.346 |
|
| 2018 |
Kato K, Uike N, Wake A, Yoshimitsu M, Tobai T, Sawayama Y, Takatsuka Y, Fukuda T, Uchida N, Eto T, Nakashima Y, Kondo T, Taguchi J, Miyamoto T, Nakamae H, et al. The outcome and characteristics of patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation. Hematological Oncology. PMID 30171618 DOI: 10.1002/Hon.2558 |
0.491 |
|
| 2018 |
Matsue K, Kumagai K, Sugiura I, Ishikawa T, Igarashi T, Sato T, Uchiyama M, Miyamoto T, Ono T, Ueda Y, Kiguchi T, Sunaga Y, Sasaki T, Suzuki K. Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study. International Journal of Hematology. PMID 30168086 DOI: 10.1007/S12185-018-2524-1 |
0.406 |
|
| 2018 |
Sugita J, Kagaya Y, Miyamoto T, Shibasaki Y, Nagafuji K, Ota S, Furukawa T, Nara M, Akashi K, Taniguchi S, Harada M, Matsuo K, Teshima T. Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide. Bone Marrow Transplantation. PMID 30087460 DOI: 10.1038/S41409-018-0279-1 |
0.421 |
|
| 2018 |
Matsue K, Kumagai K, Sugiura I, Ishikawa T, Igarashi T, Sato T, Uchiyama M, Miyamoto T, Ono T, Ueda Y, Kiguchi T, Sunaga Y, Sasaki T, Suzuki K. Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study. International Journal of Hematology. PMID 30043330 DOI: 10.1007/S12185-018-2505-4 |
0.411 |
|
| 2018 |
Usuki K, Sakura T, Kobayashi Y, Miyamoto T, Iida H, Morita S, Bahceci E, Kaneko M, Kusano M, Yamada S, Takeshita S, Miyawaki S, Naoe T. Clinical Profile of Gilteritinib in Japanese Patients with Relapsed/Refractory AML: an Open-Label Phase 1 Study. Cancer Science. PMID 30039554 DOI: 10.1111/Cas.13749 |
0.34 |
|
| 2018 |
Yoshimoto G, Mori Y, Kato K, Shima T, Miyawaki K, Kikushige Y, Kamezaki K, Numata A, Maeda T, Takenaka K, Iwasaki H, Teshima T, Akashi K, Miyamoto T. Human Herpes Virus-6-associated Encephalitis/Myelitis mimicking Calcineurin inhibitor induced pain syndrome in allogeneic stem cell transplantation recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30026111 DOI: 10.1016/J.Bbmt.2018.07.017 |
0.374 |
|
| 2018 |
Mori Y, Yoshimoto G, Nishida R, Sugio T, Miyawaki K, Shima T, Nagasaki Y, Miyake N, Harada Y, Kunisaki Y, Kamezaki K, Numata A, Kato K, Shiratsuchi M, Maeda T, ... ... Miyamoto T, et al. Gastrointestinal graft-versus-host disease is a risk factor for post-engraftment blood stream infection in allogeneic hematopoietic stem cell transplant recipients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29909153 DOI: 10.1016/J.Bbmt.2018.06.002 |
0.433 |
|
| 2018 |
Mori Y, Yoshimoto G, Yuda JI, Hayashi M, Odawara J, Kuriyama T, Sugio T, Miyawaki K, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Maeda T, Miyamoto T, Akashi K. Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation. Leukemia & Lymphoma. 1-3. PMID 29741437 DOI: 10.1080/10428194.2018.1466295 |
0.423 |
|
| 2018 |
Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, et al. The Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: a Nation-Wide Survey in Japan. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29409882 DOI: 10.1016/J.Bbmt.2018.01.026 |
0.452 |
|
| 2018 |
Ishikawa J, Matsumura I, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Matsuoka KI, Shibayama H, Hino M, Hirase C, Kamimura T, Shimose T, Akashi K, Kanakura Y. Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial). International Journal of Hematology. PMID 29362980 DOI: 10.1007/S12185-018-2401-Y |
0.335 |
|
| 2018 |
Muta T, Miyamoto T, Kamimura T, Kanda Y, Nohgawa M, Ueda Y, Iwato K, Sasaki O, Mori T, Uchida N, Iida S, Fukuda T, Atsuta Y, Sunami K. Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan. Acta Haematologica. 139: 35-44. PMID 29339642 DOI: 10.1159/000484652 |
0.432 |
|
| 2018 |
Kikushige Y, Miyamoto T. I. Understanding the Pathogenesis of Acute Myeloid Leukemia through Leukemic Stem Cells Nihon Naika Gakkai Zasshi. 107: 1272-1278. DOI: 10.2169/Naika.107.1272 |
0.425 |
|
| 2018 |
Shima T, Davis AG, Johnson DT, Kochi Y, Miyauchi S, Stoner SA, Yuda J, Miyamoto T, Zhou J, Ball ED, Akashi K, Zhang D. CPSF1-Mediated Acute Myeloid Leukemia Fusion 3'UTR Alternation Is a Potential Therapeutic Target Blood. 132: 885-885. DOI: 10.1182/Blood-2018-99-119199 |
0.345 |
|
| 2018 |
Hayashi M, Sakoda T, Kikushige Y, Irifune H, Yoshimoto G, Miyamoto T, Akashi K. Evaluation of TIM-3+ LSCs Is a Highly Sensitive MRD Monitoring Strategy to Predict AML Relapse after Allogenic Stem Cell Transplantation Blood. 132: 1390-1390. DOI: 10.1182/Blood-2018-99-116640 |
0.413 |
|
| 2018 |
Nagafuji K, Miyamoto T, Eto T, Ogawa R, Uchida N, Takase K, Kawano N, Fujisaki T, Kamimura T, Wake A, Okumura H, Miyazaki Y, Takamatsu Y, Kurokawa T, Ohno Y, et al. Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Â Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study) Blood. 132: 3970-3970. DOI: 10.1182/Blood-2018-99-112848 |
0.31 |
|
| 2018 |
Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J. Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT Blood. 132: 4635-4635. DOI: 10.1182/Blood-2018-99-112796 |
0.332 |
|
| 2018 |
Kobayashi Y, Zimmerman ZF, Oh I, Maeda Y, Minami H, Miyamoto T, Sakura T, Iida H, Chen Y, Kiyoi H. Phase 2 Study of Blinatumomab in Japanese Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) Blood. 132: 5167-5167. DOI: 10.1182/Blood-2018-99-112584 |
0.321 |
|
| 2018 |
Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka K, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Mori T. Mixed Chimerism and Secondary Engraftment Failure in Allogeneic Transplantation for Aplastic Anemia Blood. 132: 4631-4631. DOI: 10.1182/Blood-2018-99-111175 |
0.373 |
|
| 2018 |
Sugita J, Kagaya Y, Miyamoto T, Shibasaki Y, Nagafuji K, Ota S, Furukawa T, Nara M, Matsuo K, Akashi K, Taniguchi S, Harada M, Teshima T. Myeloablative Versus Reduced-Intensity Conditioning in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Using Posttransplant Cyclophosphamide Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.629 |
0.439 |
|
| 2018 |
Uchida N, Eto T, Sakura T, Aisa Y, Fujishima N, Gomyo H, Nishikawa A, Maeda Y, Miyamoto T, Nagafuji K, Kishimoto J, Teshima T, Taniguchi S, Harada M, Akashi K. Prospective Multicenter Phase II Study of Myeloablative Conditioning of Iv Busulfan, Fludarabine +/− Low Dose TBI Intensified by G-CSF-Priming and Cytarabine for Myeloid Malignancies in Older Patients (≥55 Years): Final Analysis of the JSCT FB13 Study Biology of Blood and Marrow Transplantation. 24: S408. DOI: 10.1016/J.Bbmt.2017.12.421 |
0.309 |
|
| 2018 |
Uchida N, Matsumoto K, Sakura T, Hidaka M, Miyamoto T, Eto T, Maeda Y, Murayama T, Fujishima N, Yoshimoto G, Morita K, Kishimoto J, Taniguchi S, Mori S, Akashi K, et al. Myeloablative Conditioning Using Intravenous Busulfan for Older Patients (55 Years and Older) in Allogeneic Stem Cell Transplantation -Final Analysis of FB09 and Fb10 Study of JSCT- Biology of Blood and Marrow Transplantation. 24: S405-S406. DOI: 10.1016/J.Bbmt.2017.12.417 |
0.443 |
|
| 2017 |
Takamatsu H, Wee RK, Zaimoku Y, Murata R, Zheng J, Moorhead M, Carlton VEH, Kong KA, Takezako N, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, et al. A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation. British Journal of Haematology. PMID 29270982 DOI: 10.1111/Bjh.15002 |
0.431 |
|
| 2017 |
Miyamoto T, Nagafuji K, Fujisaki T, Uchida N, Matsue K, Henzan H, Ogawa R, Takase K, Aoki T, Hidaka M, Teshima T, Taniguchi S, Akashi K, Harada M. Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission. International Journal of Hematology. PMID 29243031 DOI: 10.1007/S12185-017-2389-8 |
0.436 |
|
| 2017 |
Sasaki K, Mori Y, Yoshimoto G, Sakoda T, Kato K, Inadomi K, Kamezaki K, Takenaka K, Iwasaki H, Maeda T, Miyamoto T, Akashi K. Successful treatment of Ph ALL with hematopoietic stem cell transplantation from the same HLA-haploidentical related donor of previous liver transplantation. Leukemia & Lymphoma. 1-3. PMID 29164981 DOI: 10.1080/10428194.2017.1403021 |
0.416 |
|
| 2017 |
Yoshimitsu M, Tanosaki R, Kato K, Ishida T, Choi I, Takatsuka Y, Fukuda T, Eto T, Hidaka M, Uchida N, Miyamoto T, Nakashima Y, Moriuchi Y, Nagafuji K, Miyazaki Y, et al. Risk Assessment in Adult T-Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29155320 DOI: 10.1016/J.Bbmt.2017.11.005 |
0.422 |
|
| 2017 |
Miyake N, Chong Y, Nishida R, Takenaka K, Kato K, Miyamoto T, Aono A, Takaki A, Mitarai S, Shimoda S, Shimono N, Akashi K. Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy. PMID 28988958 DOI: 10.1016/J.Jiac.2017.08.011 |
0.36 |
|
| 2017 |
Kikushige Y, Miyamoto T, Akashi K. Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 58: 1838-1843. PMID 28978822 DOI: 10.11406/Rinketsu.58.1838 |
0.43 |
|
| 2017 |
Takamatsu H, Takezako N, Zheng J, Moorhead M, Carlton VEH, Kong KA, Murata R, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, et al. Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem cell transplantation. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28945825 DOI: 10.1093/Annonc/Mdx340 |
0.409 |
|
| 2017 |
Uchida M, Mori Y, Nakamura T, Kato K, Kamezaki K, Takenaka K, Shiratsuchi M, Kadoyama K, Miyamoto T, Akashi K. Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP. Biological & Pharmaceutical Bulletin. 40: 1499-1505. PMID 28867732 DOI: 10.1248/Bpb.B17-00318 |
0.319 |
|
| 2017 |
Onishi Y, Mori T, Kako S, Koh H, Uchida N, Kondo T, Kobayashi T, Yabe H, Miyamoto T, Kato K, Suzuki R, Nakao S, Yamazaki H. Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28844947 DOI: 10.1016/J.Bbmt.2017.08.020 |
0.462 |
|
| 2017 |
Sakoda T, Kanamitsu Y, Mori Y, Sasaki K, Yonemitsu E, Nagae K, Yoshimoto G, Kamezaki K, Kato K, Takenaka K, Miyamoto T, Furue M, Iwasaki H, Akashi K. Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation. Internal Medicine (Tokyo, Japan). 56: 2481-2485. PMID 28824063 DOI: 10.2169/Internalmedicine.8491-16 |
0.464 |
|
| 2017 |
Yuda J, Miyamoto T, Odawara J, Ohkawa Y, Semba Y, Hayashi M, Miyamura K, Tanimoto M, Yamamoto K, Taniwaki M, Akashi K. Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response. Cancer Science. PMID 28801986 DOI: 10.1111/Cas.13353 |
0.32 |
|
| 2017 |
Ogata M, Oshima K, Ikebe T, Takano K, Kanamori H, Kondo T, Ueda Y, Mori T, Hashimoto H, Ogawa H, Eto T, Ueki T, Miyamoto T, Ichinohe T, Atsuta Y, et al. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 52: 1563-1570. PMID 28783148 DOI: 10.1038/Bmt.2017.175 |
0.44 |
|
| 2017 |
Minami Y, Minami H, Miyamoto T, Yoshimoto G, Kobayashi Y, Munakata W, Onishi Y, Kobayashi M, Ikuta M, Chan G, Woolfson A, Ono C, Shaik MN, Fujii Y, Zheng X, et al. Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies. Cancer Science. PMID 28556364 DOI: 10.1111/Cas.13285 |
0.314 |
|
| 2017 |
Mizutani M, Takami A, Hara M, Mizuno S, Yanada M, Chou T, Uchiyama H, Ohashi K, Miyamoto T, Ozawa Y, Imataki O, Kobayashi N, Uchida N, Kanamori H, Kamimura T, et al. Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28533061 DOI: 10.1016/J.Bbmt.2017.05.008 |
0.481 |
|
| 2017 |
Miyawaki K, Iwasaki H, Jiromaru T, Kusumoto H, Yurino A, Sugio T, Uehara Y, Odawara J, Daitoku S, Kunisaki Y, Mori Y, Arinobu Y, Tsuzuki H, Kikushige Y, Iino T, ... ... Miyamoto T, et al. Identification of unipotent megakaryocyte progenitors in human hematopoiesis. Blood. PMID 28336526 DOI: 10.1182/Blood-2016-09-741611 |
0.431 |
|
| 2017 |
Miyamoto T, Fukuda T, Nakashima M, Henzan T, Kusakabe S, Kobayashi N, Sugita J, Mori T, Kurokawa M, Mori SI. Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28219836 DOI: 10.1016/J.Bbmt.2017.02.012 |
0.463 |
|
| 2017 |
Fujiwara H, Fuji S, Wake A, Kato K, Takatsuka Y, Fukuda T, Taguchi J, Uchida N, Miyamoto T, Hidaka M, Miyazaki Y, Tomoyose T, Onizuka M, Takanashi M, Ichinohe T, et al. Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study. Bone Marrow Transplantation. PMID 28067877 DOI: 10.1038/Bmt.2016.313 |
0.715 |
|
| 2017 |
Muta T, Miyamoto T, Fujisaki T, Osaki K, Ogawa R, Kato K, Aoki K, Haro T, Kamimura T, Kamezaki K, Yoshimoto G, Yamasaki S, Takenaka K, Ohno Y, Iwasaki H, et al. Significance of salvage autologous stem cell transplantation (ASCT) for patients with multiple myeloma relapsing after up-front ASCT Journal of Hematopoietic Cell Transplantation. 6: 98-107. DOI: 10.7889/HCT.6.98 |
0.388 |
|
| 2017 |
Sakoda T, Kikushige Y, Miyamoto T, Akashi K. Canonical Wnt Pathway Is Activated in Myeloid Leukemia Stem Cells Via Hematopoietic Cell Kinase That Is Phosphorylated By an Autocrine TIM-3/Galectin-9 Signaling Blood. 130: 3919-3919. DOI: 10.1182/Blood.V130.Suppl_1.3919.3919 |
0.364 |
|
| 2016 |
Ogiya D, Shibayama H, Nakatani E, Ando K, Suzuki K, Kuroda Y, Uchida T, Maruyama D, Matsumoto M, Matsue K, Iida S, Terui Y, Ri M, Chou T, Aotsuka N, ... ... Miyamoto T, et al. Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102). [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 57: 2311-2318. PMID 27941278 DOI: 10.11406/Rinketsu.57.2311 |
0.385 |
|
| 2016 |
Shimoji S, Hashimoto D, Tsujigiwa H, Miyawaki K, Kato K, Takahashi S, Ogasawara R, Jiromaru T, Iwasaki H, Miyamoto T, Akashi K, Teshima T. Graft-versus-host disease targets ovary and causes female infertility in mice. Blood. PMID 27903524 DOI: 10.1182/Blood-2016-07-728337 |
0.413 |
|
| 2016 |
Tochigi T, Aoki T, Kikushige Y, Kamimura T, Ito Y, Shima T, Yamauchi T, Mori Y, Yoshimoto G, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Akashi K, Miyamoto T. Mobilization of human immature hematopoietic progenitors through combinatory use of bortezomib and immunomodulatory drugs. International Journal of Hematology. PMID 27873175 DOI: 10.1007/S12185-016-2148-2 |
0.423 |
|
| 2016 |
Suetsugu K, Ikesue H, Miyamoto T, Shiratsuchi M, Yamamoto-Taguchi N, Tsuchiya Y, Matsukawa K, Uchida M, Watanabe H, Akashi K, Masuda S. Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. PMID 27822915 DOI: 10.1007/S12185-016-2135-7 |
0.382 |
|
| 2016 |
Sugita J, Miyamoto T, Kawashima N, Hatsumi N, Anzai N, Kaneko H, Nara M, Minauchi K, Harada M, Teshima T. Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation. Bone Marrow Transplantation. 52: 323-325. PMID 27819686 DOI: 10.1038/Bmt.2016.278 |
0.412 |
|
| 2016 |
Kobayashi R, Mitsui T, Fujita N, Osumi T, Aoki T, Aoki K, Suzuki R, Fukuda T, Miyamoto T, Kato K, Nakamae H, Goto H, Eto T, Inoue M, Mori T, et al. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation. International Journal of Hematology. PMID 27787746 DOI: 10.1007/S12185-016-2120-1 |
0.426 |
|
| 2016 |
Miyamura K, Miyamoto T, Tanimoto M, Yamamoto K, Kimura S, Kawaguchi T, Matsumura I, Hata T, Tsurumi H, Saito S, Hino M, Tadokoro S, Meguro K, Hyodo H, Yamamoto M, et al. Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy. Leukemia Research. 51: 11-18. PMID 27771544 DOI: 10.1016/J.Leukres.2016.09.009 |
0.321 |
|
| 2016 |
Miyamoto T, Takashima S, Kato K, Takase K, Yoshimoto G, Yoshida S, Henzan H, Osaki K, Kamimura T, Iwasaki H, Eto T, Teshima T, Nagafuji K, Akashi K. Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation. International Journal of Hematology. PMID 27686673 DOI: 10.1007/S12185-016-2093-0 |
0.405 |
|
| 2016 |
Yurino A, Takenaka K, Yamauchi T, Nunomura T, Uehara Y, Jinnouchi F, Miyawaki K, Kikushige Y, Kato K, Miyamoto T, Iwasaki H, Kunisaki Y, Akashi K. Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations. Stem Cell Reports. PMID 27499200 DOI: 10.1016/J.Stemcr.2016.07.002 |
0.368 |
|
| 2016 |
Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, ... ... Miyamoto T, et al. A Comparison of Outcomes for Cord Blood Transplant and Unrelated Bone Marrow Transplant in Adult Aplastic Anemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27401034 DOI: 10.1016/J.Bbmt.2016.07.002 |
0.416 |
|
| 2016 |
Shima T, Kamezaki K, Higashioka K, Takashima S, Yoshimoto G, Kato K, Muta T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K. Ascites Retention during Mogamulizumab Treatment in a Patient with Adult T-cell Leukemia/lymphoma. Internal Medicine (Tokyo, Japan). 55: 1793-6. PMID 27374686 DOI: 10.2169/Internalmedicine.55.5987 |
0.375 |
|
| 2016 |
Sugio T, Kato K, Aoki T, Ohta T, Saito N, Yoshida S, Kawano I, Henzan H, Kadowaki M, Takase K, Muta T, Miyawaki K, Yamauchi T, Shima T, Takashima S, ... ... Miyamoto T, et al. Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27220263 DOI: 10.1016/J.Bbmt.2016.05.017 |
0.482 |
|
| 2016 |
Daitoku S, Takenaka K, Yamauchi T, Yurino A, Jinnouchi F, Nunomura T, Eto T, Kamimura T, Higuchi M, Harada N, Saito N, Miyamoto T, Iwasaki H, Akashi K. Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis. Experimental Hematology. 44: 817-825.e3. PMID 27185380 DOI: 10.1016/J.Exphem.2016.05.001 |
0.312 |
|
| 2016 |
Murayama T, Fukuda T, Okumura H, Sunami K, Sawazaki A, Maeda Y, Tsurumi H, Uike N, Hidaka T, Takatsuka Y, Eto T, Tsuda H, Fujisaki T, Miyamoto T, Tsuneyoshi N, et al. Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04). International Journal of Hematology. PMID 27084252 DOI: 10.1007/S12185-016-1976-4 |
0.44 |
|
| 2016 |
Kuriyama T, Kato K, Sakamoto K, Hayashi M, Takashima S, Mori Y, Takenaka K, Iwasaki H, Teshima T, Harada N, Nagafuji K, Miyamoto T, Akashi K. Cord Blood Transplantation Following Reduced-intensity Conditioning for Adult-onset Inherited Hemophagocytic Lymphohistiocytosis. Internal Medicine (Tokyo, Japan). 55: 667-71. PMID 26984088 DOI: 10.2169/Internalmedicine.55.5241 |
0.426 |
|
| 2016 |
Kitanaka A, Takenaka K, Shide K, Miyamoto T, Kondo T, Ozawa K, Kurokawa M, Akashi K, Shimoda K. Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients. International Journal of Hematology. 103: 423-8. PMID 26791378 DOI: 10.1007/S12185-016-1940-3 |
0.315 |
|
| 2016 |
Tochigi T, Kikushige Y, Miyamoto T, Akashi K. IMiDs Cause Thrombocytopenia By the Inhibition of Proplatelet Formation, through Blocking Estradiol Autocrine Loop in Human Megakaryocytes Blood. 128: 894-894. DOI: 10.1182/Blood.V128.22.894.894 |
0.339 |
|
| 2016 |
Kadowaki N, Kawaguchi T, Kuroda J, Nakamae H, Matsumura I, Miyamoto T, Ishikawa J, Nagafuji K, Imamura Y, Yamazaki H, Shimokawa M, Akashi K, Kanakura Y. Discontinuation of Nilotinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Deep Molecular Responses for at Least 2 Years: A Multicenter Phase 2 Stop Nilotinib (Nilst) Trial Blood. 128: 790-790. DOI: 10.1182/Blood.V128.22.790.790 |
0.308 |
|
| 2016 |
Miyakoshi S, Usuki K, Matsumura I, Ueda Y, Iwasaki H, Miyamoto T, Origuchi M, Tagashira S, Naoi I, Naoe T, Kizaki M, Heike Y, Akashi K, Miyazaki Y. Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS) Blood. 128: 4335-4335. DOI: 10.1182/Blood.V128.22.4335.4335 |
0.354 |
|
| 2016 |
Jinnouchi F, Takenaka K, Iwamoto C, Yamauchi T, Yurino A, Nunomura T, Kikushige Y, Kato K, Miyamoto T, Akashi K. Introduction of Macrophage Tolerance By Human SIRPA Knock-in Enhances Peripheral Reconstitution of Human Hematopoiesis in Xenotransplantation Model Blood. 128: 29-29. DOI: 10.1182/Blood.V128.22.29.29 |
0.372 |
|
| 2016 |
Kochi Y, Kikushige Y, Miyamoto T, Akashi K. Identification of ASCT1 As a Candidate Molecule Enhancing Antioxidant Activity in Primary Human AML Cells Blood. 128: 1674-1674. DOI: 10.1182/Blood.V128.22.1674.1674 |
0.385 |
|
| 2016 |
Yoshimoto G, Kato K, Mori Y, Kamezaki K, Takenaka K, Iwasaki H, Miyamoto T, Akashi K. Allogenic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Induction Failure Biology of Blood and Marrow Transplantation. 22: S214-S215. DOI: 10.1016/J.Bbmt.2015.11.613 |
0.465 |
|
| 2016 |
Mizutani M, Takami A, Hara M, Mizuno S, Yanada M, Ohashi K, Usuki K, Uchiyama H, Chou T, Miyamoto T, Tanaka J, Atsuta Y, Yano S. A Comparison of the Outcomes of Autologous and Unrelated-Donor Transplantation in Adult Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission Biology of Blood and Marrow Transplantation. 22: S30-S31. DOI: 10.1016/J.Bbmt.2015.11.298 |
0.411 |
|
| 2015 |
Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T, Ohwada C, Miyamura K, Nawa Y, Kurokawa M, Mizuno I, Mori T, Onizuka M, Taguchi J, Ichinohe T, et al. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. Bone Marrow Transplantation. PMID 26595082 DOI: 10.1038/Bmt.2015.283 |
0.42 |
|
| 2015 |
Kikushige Y, Miyamoto T. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia. Oncology. 89: 28-32. PMID 26551150 DOI: 10.1159/000431062 |
0.422 |
|
| 2015 |
Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T, Hidaka M, Moriuchi Y, Miyamoto T, Uike N, Taguchi J, Eto T, Tomoyose T, Kondo T, Yamanoha A, et al. Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma. Bone Marrow Transplantation. PMID 26524263 DOI: 10.1038/Bmt.2015.265 |
0.449 |
|
| 2015 |
Takashima S, Miyamoto T, Kamimura T, Yoshimoto G, Yoshida S, Henzan H, Takase K, Kato K, Ito Y, Ohno Y, Nagafuji K, Eto T, Teshima T, Akashi K. Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. International Journal of Hematology. PMID 26475283 DOI: 10.1007/S12185-015-1883-0 |
0.424 |
|
| 2015 |
Kikushige Y, Miyamoto T, Yuda J, Jabbarzadeh-Tabrizi S, Shima T, Takayanagi S, Niiro H, Yurino A, Miyawaki K, Takenaka K, Iwasaki H, Akashi K. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression. Cell Stem Cell. 17: 341-52. PMID 26279267 DOI: 10.1016/J.Stem.2015.07.011 |
0.406 |
|
| 2015 |
Shima T, Iwasaki H, Yamauchi T, Kadowaki M, Kiyosuke M, Mochimaru T, Takenaka K, Miyamoto T, Akashi K, Teshima T. Preserved in vivo reconstitution ability of PBSCs cryopreserved for a decade at -80 °C. Bone Marrow Transplantation. PMID 26098951 DOI: 10.1038/Bmt.2015.147 |
0.377 |
|
| 2015 |
Sugita J, Kawashima N, Fujisaki T, Kakihana K, Ota S, Matsuo K, Miyamoto T, Akashi K, Taniguchi S, Harada M, Teshima T. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1646-52. PMID 26093044 DOI: 10.1016/J.Bbmt.2015.06.008 |
0.486 |
|
| 2015 |
Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Tsudo M, Kobayashi H, Maesako Y, Eto T, Adachi S, Ichinohe T, et al. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch. American Journal of Hematology. 90: 618-23. PMID 25850370 DOI: 10.1002/Ajh.24028 |
0.436 |
|
| 2015 |
Minami M, Shima T, Kato K, Yamamoto H, Tsuchihashi K, Oku S, Shimokawa T, Tochigi T, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Oda Y, Miyamoto T, Akashi K. Successful treatment of adult Langerhans cell histiocytosis with intensified chemotherapy. International Journal of Hematology. PMID 25753226 DOI: 10.1007/S12185-015-1778-0 |
0.339 |
|
| 2015 |
Uryu H, Hashimoto D, Kato K, Hayase E, Matsuoka S, Ogasawara R, Takahashi S, Maeda Y, Iwasaki H, Miyamoto T, Saijo S, Iwakura Y, Hill GR, Akashi K, Teshima T. α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice. Blood. 125: 3014-23. PMID 25740827 DOI: 10.1182/Blood-2014-12-615781 |
0.382 |
|
| 2015 |
Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, Uike N, Saburi Y, Nosaka K, Utsunomiya A, Tobinai K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, ... ... Miyamoto T, et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. British Journal of Haematology. 169: 672-82. PMID 25733162 DOI: 10.1111/Bjh.13338 |
0.33 |
|
| 2015 |
Yamasaki S, Yoshimoto G, Ogawa R, Aoki K, Higuchi M, Harada N, Arima F, Kondo S, Matubara F, Takahashi T, Uike N, Miyamoto T, Okamura S, Akashi K. Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics. Annals of Hematology. 94: 1159-65. PMID 25704584 DOI: 10.1007/S00277-015-2338-7 |
0.448 |
|
| 2015 |
Kikushige Y, Miyamoto T. Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia. International Journal of Hematology. PMID 25644149 DOI: 10.1007/S12185-015-1740-1 |
0.44 |
|
| 2015 |
Takase K, Miyamoto T. [Allogeneic hematopoietic stem cell transplantation for multiple myeloma]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 73: 107-13. PMID 25626314 |
0.355 |
|
| 2015 |
Takamatsu H, Honda S, Miyamoto T, Yokoyama K, Hagiwara S, Ito T, Tomita N, Iida S, Iwasaki T, Sakamaki H, Suzuki R, Sunami K. Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era. Cancer Science. 106: 179-85. PMID 25530023 DOI: 10.1111/Cas.12594 |
0.374 |
|
| 2015 |
Miyawaki K, Arinobu Y, Iwasaki H, Kohno K, Tsuzuki H, Iino T, Shima T, Kikushige Y, Takenaka K, Miyamoto T, Akashi K. CD41 marks the initial myelo-erythroid lineage specification in adult mouse hematopoiesis: redefinition of murine common myeloid progenitor. Stem Cells (Dayton, Ohio). 33: 976-87. PMID 25446279 DOI: 10.1002/Stem.1906 |
0.364 |
|
| 2015 |
Ito Y, Miyamoto T, Kamimura T, Aoki K, Henzan H, Aoki T, Shiratsuchi M, Kato K, Nagafuji K, Ogawa R, Eto T, Iwasaki H, Akashi K. Characteristics of patients with development of large granular lymphocyte expansion among dasatinib-treated patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantation. Clinical Lymphoma, Myeloma & Leukemia. 15: e47-54. PMID 25445469 DOI: 10.1016/J.Clml.2014.09.006 |
0.478 |
|
| 2015 |
Tochigi T, Aoki T, Kikushige Y, Kamimura T, Yamauchi T, Kato K, Takenaka K, Miyamoto T, Akashi K. Mobilization of Human Immature Hematopoietic Progenitors after Combinatory Use of Bortezomib and Immunomodulatory Drugs Blood. 126: 316-316. DOI: 10.1182/Blood.V126.23.316.316 |
0.452 |
|
| 2015 |
Sugio T, Kato K, Aoki T, Ota T, Saito N, Yoshida S, Kawano I, Henzan H, Takase K, Muta T, Miyawaki K, Shima T, Takashima S, Yamauchi T, Mori Y, ... ... Miyamoto T, et al. Prior Use of Mogamulizumab to Allogenic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-Versus-Host Disease Blood. 126: 1940-1940. DOI: 10.1182/Blood.V126.23.1940.1940 |
0.507 |
|
| 2015 |
Yoshimoto G, Miyamoto T, Kato K, Mori Y, Kamezaki K, Takenaka K, Iwasaki H, Akashi K. Incidence and Differential Diagnosis of Human Herpes Virus-6 Associated Encephalitis/Myelitis in Allogeneic Stem Cell Transplantation That Mimics Calcineurin Inhibitor-Induced Pain Syndrome Blood. 126: 1912-1912. DOI: 10.1182/Blood.V126.23.1912.1912 |
0.397 |
|
| 2015 |
Takamatsu H, Murata R, Zheng J, Moorhead M, Takezako N, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Yoshida T, et al. Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation Blood. 126: 1788-1788. DOI: 10.1182/Blood.V126.23.1788.1788 |
0.404 |
|
| 2015 |
Wee RK, Takamatsu H, Murata R, Zheng J, Moorhead M, Takezako N, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, et al. A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation Blood. 126: 1782-1782. DOI: 10.1182/Blood.V126.23.1782.1782 |
0.366 |
|
| 2015 |
Minami M, Miyamoto T, Arita T, Kamimura T, Yuda J, Kikushige Y, Mori Y, Yoshimoto G, Kamezaki K, Kato K, Shiratsuchi M, Takenaka K, Iwasaki H, Yamasaki S, Muta T, et al. Comparative Analysis of Tyrosine Kinase Inhibitors-Related Pulmonary Hypertension in the Patients Treated By Imatinib, Dasatinib and Nilotinib Blood. 126: 1583-1583. DOI: 10.1182/Blood.V126.23.1583.1583 |
0.304 |
|
| 2015 |
Sugita J, Kawashima N, Fujisaki T, Kakihana K, Ota S, Matsuo K, Miyamoto T, Akashi K, Taniguchi S, Harada M, Teshima T. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning Biology of Blood and Marrow Transplantation. 21: 1646-1652. DOI: 10.1016/j.bbmt.2015.06.008 |
0.324 |
|
| 2015 |
Sugita J, Kawashima N, Fujisaki T, Kakihana K, Uchida N, Maeda Y, Ota S, Matsuo K, Miyamoto T, Nagafuji K, Eto T, Akashi K, Taniguchi S, Harada M, Teshima T. Prospective Multicenter Phase II Study of HLA-Haploidentical Peripheral Blood Stem Cell Transplantation after Reduced-Intensity Conditioning with Post-Transplant Cyclophosphamide: First Analysis of the JSCT Haplo13 Study Biology of Blood and Marrow Transplantation. 21: S313-S314. DOI: 10.1016/J.Bbmt.2014.11.499 |
0.512 |
|
| 2014 |
Kato K, Ohno Y, Kamimura T, Kusumoto H, Tochigi T, Jinnouchi F, Kohno K, Kuriyama T, Henzan H, Takase K, Kawano I, Kadowaki M, Nawata R, Muta T, Eto T, ... ... Miyamoto T, et al. Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma. Bone Marrow Transplantation. 49: 1543-4. PMID 25133892 DOI: 10.1038/Bmt.2014.189 |
0.324 |
|
| 2014 |
Shima T, Miyamoto T, Kikushige Y, Yuda J, Tochigi T, Yoshimoto G, Kato K, Takenaka K, Iwasaki H, Mizuno S, Goto N, Akashi K. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell. Experimental Hematology. 42: 955-65.e1-5. PMID 25101977 DOI: 10.1016/J.Exphem.2014.07.267 |
0.424 |
|
| 2014 |
Kikushige Y, Miyamoto T. Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis. International Journal of Hematology. 100: 335-40. PMID 25100497 DOI: 10.1007/S12185-014-1651-6 |
0.425 |
|
| 2014 |
Iida M, Fukuda T, Uchida N, Murata M, Aotsuka N, Minagawa K, Oohashi K, Fukushima K, Kondo T, Eto T, Miyamoto T, Morishima Y, Nagamura T, Atsuta Y, Suzuki R. Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft-vs.-host disease in adult patients in Japan. Clinical Transplantation. 28: 980-9. PMID 24943923 DOI: 10.1111/Ctr.12405 |
0.465 |
|
| 2014 |
Takashima S, Eto T, Shiratsuchi M, Hidaka M, Mori Y, Kato K, Kamezaki K, Oku S, Henzan H, Takase K, Matsushima T, Takenaka K, Iwasaki H, Miyamoto T, Akashi K, et al. The use of oral beclomethasone dipropionate in the treatment of gastrointestinal graft-versus-host disease: the experience of the Fukuoka blood and marrow transplantation (BMT) group. Internal Medicine (Tokyo, Japan). 53: 1315-20. PMID 24930650 DOI: 10.2169/Internalmedicine.53.1858 |
0.369 |
|
| 2014 |
Takashima S, Miyamoto T, Kadowaki M, Ito Y, Aoki T, Takase K, Shima T, Yoshimoto G, Kato K, Muta T, Shiratsuchi M, Takenaka K, Iwasaki H, Teshima T, Kamimura T, et al. Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients. International Journal of Hematology. 100: 159-64. PMID 24928523 DOI: 10.1007/S12185-014-1611-1 |
0.392 |
|
| 2014 |
Yuda J, Kato K, Kikushige Y, Ohkusu K, Kiyosuke M, Sakamoto K, Oku S, Miyake N, Kadowaki M, Iino T, Tanimoto K, Takenaka K, Iwasaki H, Miyamoto T, Shimono N, et al. Successful treatment of invasive zygomycosis based on a prompt diagnosis using molecular methods in a patient with acute myelogenous leukemia. Internal Medicine (Tokyo, Japan). 53: 1087-91. PMID 24827491 DOI: 10.2169/Internalmedicine.53.1366 |
0.426 |
|
| 2014 |
Ogura M, Ishida T, Hatake K, Taniwaki M, Ando K, Tobinai K, Fujimoto K, Yamamoto K, Miyamoto T, Uike N, Tanimoto M, Tsukasaki K, Ishizawa K, Suzumiya J, Inagaki H, et al. Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1157-63. PMID 24616310 DOI: 10.1200/Jco.2013.52.0924 |
0.387 |
|
| 2014 |
Iwamoto C, Takenaka K, Urata S, Yamauchi T, Shima T, Kuriyama T, Daitoku S, Saito Y, Miyamoto T, Iwasaki H, Kitabayashi I, Itoh K, Kishimoto J, Kohda D, Matozaki T, et al. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment. Experimental Hematology. 42: 163-171.e1. PMID 24269920 DOI: 10.1016/J.Exphem.2013.11.005 |
0.337 |
|
| 2014 |
Koyama M, Hashimoto D, Nagafuji K, Eto T, Ohno Y, Aoyama K, Iwasaki H, Miyamoto T, Hill GR, Akashi K, Teshima T. Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning. Bone Marrow Transplantation. 49: 110-5. PMID 24013691 DOI: 10.1038/Bmt.2013.134 |
0.413 |
|
| 2014 |
Kikushige Y, Yuda J, Shima T, Miyamoto T, Akashi K. TIM-3 and Its Ligand, Galectin-9 Constitute a Pan-Myeloid Autocrine Loop to Develop and Maintain Malignant Stem Cells in Most Human Myeloid Leukemia Blood. 124: 835-835. DOI: 10.1182/Blood.V124.21.835.835 |
0.452 |
|
| 2014 |
Yuda J, Miyamoto T, Odawara J, Kikushige Y, Ohkawa Y, Akashi K. Persistence of Abnormally-Spliced, Functionally-Dead BCR-ABL Variants Is a Critical Obstacle to Achieve Sustained Complete Molecular Response in CML Patients: Results of a Quantitative, Highly-Sensitive, Deep Sequencing Study Blood. 124: 4525-4525. DOI: 10.1182/Blood.V124.21.4525.4525 |
0.341 |
|
| 2014 |
Kawajiri C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Tsudo M, Iwasaki T, Shigematsu A, Suzuki R, et al. The Efficacy and Long-Term Outcomes of ASCT in POEMS Syndrome: A Multicenter Retrospective Study in Japan Blood. 124: 3970-3970. DOI: 10.1182/Blood.V124.21.3970.3970 |
0.437 |
|
| 2014 |
Kato K, Miyamoto T, Yonemoto K, Uchida N, Ogawa H, Fukuda T, Takahashi S, Ohashi K, Eto T, Nagamura-Inoue T, Sakamaki H, Morishima Y, Suzuki R, Atsuta Y, Akashi K. Second Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Relapse of Hematological Malignancies after First Allo-HSCT Blood. 124: 3947-3947. DOI: 10.1182/Blood.V124.21.3947.3947 |
0.488 |
|
| 2014 |
Muta T, Iida S, Matsue K, Sunami K, Isoda J, Harada N, Saburi Y, Okamura S, Kumagae K, Watanabe J, Kuroda J, Aoki K, Ogawa R, Miyamoto T, Akashi K, et al. Predictive Significance of Serum Beta 2-Microglobulin Levels and M-Protein Velocity for Symptomatic Progression of Smoldering Multiple Myeloma Blood. 124: 3379-3379. DOI: 10.1182/Blood.V124.21.3379.3379 |
0.321 |
|
| 2014 |
Takamatsu H, Murata R, Zheng J, Moorhead M, Takezako N, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Yoshida T, et al. Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma Blood. 124: 2003-2003. DOI: 10.1182/Blood.V124.21.2003.2003 |
0.381 |
|
| 2014 |
Kohno K, Takase K, Kadowaki M, Yamasaki S, Kamimura T, Ohno Y, Eto T, Miyamoto T, Okamura S, Akashi K. Cyclophosphamide Related Cardiac Complication in Hematopoietic Transplantation: Analysis of 1091 Cases in Fukuoka Blood and Marrow Transplantation Group Blood. 124: 1139-1139. DOI: 10.1182/Blood.V124.21.1139.1139 |
0.376 |
|
| 2014 |
Tsukamoto H, Ayano M, Miyamoto T, Niiro H, Arinobu Y, Akahoshi M, Akashi K. OP0093 Comparison of CD34-Selected and Unmanipulated Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Four-Year Follow-Up Results Annals of the Rheumatic Diseases. 73: 96.2-97. DOI: 10.1136/Annrheumdis-2014-Eular.3166 |
0.423 |
|
| 2014 |
Muta T, Yoshimoto G, Kohno K, Jinnouchi F, Shima T, Kamezaki K, Kato K, Takenaka K, Miyamoto T, Akashi K. Therapy Related Leukemia During Adjuvant Chemotherapy for Pancreatic Cancer Developed After Adjuvant for Breast Cancer Annals of Oncology. 25: v89. DOI: 10.1093/Annonc/Mdu436.65 |
0.397 |
|
| 2014 |
Muta T, Iida S, Matsue K, Sunami K, Isoda J, Harada N, Kuroda J, Miyamoto T, Akashi K, Takamatsu Y. Characteristics and Risk for Progression of Smoldering Multiple Myeloma: Japanese Nationwide Retrospective Survey Annals of Oncology. 25: v60. DOI: 10.1093/Annonc/Mdu435.68 |
0.362 |
|
| 2014 |
Uchida N, Hidaka M, Sakura T, Miyamoto T, Fujisaki T, Eto T, Maeda Y, Fukuno K, Matsumoto K, Morita K, Kishimoto J, Fukuda T, Teshima T, Taniguchi S, Mori S, et al. Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/- Total Body Irradiation for Older Patients (55 years and older): Final Analysis of the JSCT FB09 Study Biology of Blood and Marrow Transplantation. 20: S253. DOI: 10.1016/J.Bbmt.2013.12.426 |
0.427 |
|
| 2013 |
Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Takatsuka Y, Eto T, Miyazaki Y, Hidaka M, Uike N, Miyamoto T, Tsudo M, Sakamaki H, Morishima Y, Suzuki R, et al. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1731-9. PMID 24090597 DOI: 10.1016/J.Bbmt.2013.09.014 |
0.435 |
|
| 2013 |
Kikushige Y, Miyamoto T. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells. International Journal of Hematology. 98: 627-33. PMID 24046178 DOI: 10.1007/S12185-013-1433-6 |
0.418 |
|
| 2013 |
Ito Y, Miyamoto T, Kamimura T, Takase K, Henzan H, Sugio Y, Kato K, Ohno Y, Eto T, Teshima T, Akashi K. Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group. International Journal of Hematology. 98: 463-71. PMID 24043582 DOI: 10.1007/S12185-013-1430-9 |
0.478 |
|
| 2013 |
Miyamoto T. [Leukemia: recent progress in diagnosis and treatment. Topics: I. Recent findings in pathogenesis and pathophysiology; 1. Acute leukemia stem cells]. Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine. 102: 1652-60. PMID 23947225 DOI: 10.2169/Naika.102.1652 |
0.406 |
|
| 2013 |
Nakaike T, Kato K, Oku S, Hayashi M, Kikushige Y, Kuroiwa M, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Ohshima K, Akashi K. Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides. International Journal of Hematology. 98: 491-5. PMID 23943312 DOI: 10.1007/S12185-013-1410-0 |
0.428 |
|
| 2013 |
Eriguchi Y, Uryu H, Nakamura K, Shimoji S, Takashima S, Iwasaki H, Miyamoto T, Shimono N, Hashimoto D, Akashi K, Ayabe T, Teshima T. Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1525-9. PMID 23927965 DOI: 10.1016/J.Bbmt.2013.07.027 |
0.34 |
|
| 2013 |
Miyamoto T, Yoshimoto G, Kamimura T, Muta T, Takashima S, Ito Y, Shiratsuchi M, Choi I, Kato K, Takenaka K, Iwasaki H, Takamatsu Y, Teshima T, Akashi K. Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma. International Journal of Hematology. 98: 337-45. PMID 23877150 DOI: 10.1007/S12185-013-1402-0 |
0.418 |
|
| 2013 |
Takamatsu Y, Sunami K, Muta T, Morimoto H, Miyamoto T, Higuchi M, Uozumi K, Hata H, Tamura K. Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 study. International Journal of Hematology. 98: 179-85. PMID 23832805 DOI: 10.1007/S12185-013-1389-6 |
0.327 |
|
| 2013 |
Eto T, Takase K, Miyamoto T, Ohno Y, Kamimura T, Nagafuji K, Takamatsu Y, Teshima T, Gondo H, Taniguchi S, Akashi K, Harada M. Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission. International Journal of Hematology. 98: 186-96. PMID 23754766 DOI: 10.1007/S12185-013-1378-9 |
0.469 |
|
| 2013 |
Shimoji S, Kato K, Eriguchi Y, Takenaka K, Iwasaki H, Miyamoto T, Oda Y, Akashi K, Teshima T. Evaluating the association between histological manifestations of cord colitis syndrome with GVHD. Bone Marrow Transplantation. 48: 1249-52. PMID 23749110 DOI: 10.1038/Bmt.2013.44 |
0.414 |
|
| 2013 |
Takamatsu H, Ogawa Y, Kobayashi N, Obata K, Narisawa T, Nakayama K, Munemoto S, Aoki G, Ohata K, Kumano Y, Ozaki J, Murata R, Kondo Y, Terasaki Y, Kurokawa T, ... Miyamoto T, et al. Detection of minimal residual disease in patients with multiple myeloma using clonotype-specific PCR primers designed from DNA extracted from archival bone marrow slides. Experimental Hematology. 41: 894-902. PMID 23727584 DOI: 10.1016/J.Exphem.2013.05.004 |
0.437 |
|
| 2013 |
Uchida M, Kato K, Ikesue H, Ichinose K, Hiraiwa H, Sakurai A, Muta T, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Shiratsuchi M, Suetsugu K, Nagata K, Egashira N, et al. Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantation. Pharmacotherapy. 33: 893-901. PMID 23712662 DOI: 10.1002/Phar.1294 |
0.43 |
|
| 2013 |
Uchida M, Ikesue H, Miyamoto T, Kato K, Suetsugu K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Muta T, Iwasaki H, Teshima T, Shiratsuchi M, Egashira N, Akashi K, et al. Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation. Biological & Pharmaceutical Bulletin. 36: 819-24. PMID 23649338 DOI: 10.1248/Bpb.B12-01012 |
0.4 |
|
| 2013 |
Kanda Y, Oshima K, Kako S, Fukuda T, Uchida N, Miyamura K, Kondo Y, Nakao S, Nagafuji K, Miyamoto T, Kurokawa M, Okoshi Y, Chiba S, Ohashi Y, Takaue Y, et al. In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation. American Journal of Hematology. 88: 294-300. PMID 23450467 DOI: 10.1002/Ajh.23392 |
0.502 |
|
| 2013 |
Chiba T, Tsuji G, Mitoma H, Takahara M, Moroi Y, Miyamoto T, Furue M. Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris. Haemophilia : the Official Journal of the World Federation of Hemophilia. 19: e98-9. PMID 23419110 DOI: 10.1111/Hae.12087 |
0.316 |
|
| 2013 |
Kato K, Miyamoto T, Numata A, Nakaike T, Oka H, Yurino A, Kuriyama T, Mori Y, Yamasaki S, Muta T, Takenaka K, Iwasaki H, Teshima T, Akashi K. Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma. International Journal of Hematology. 97: 430-2. PMID 23397210 DOI: 10.1007/S12185-013-1278-Z |
0.331 |
|
| 2013 |
Nagafuji K, Miyamoto T, Eto T, Kamimura T, Taniguchi S, Okamura T, Ohtsuka E, Yoshida T, Higuchi M, Yoshimoto G, Fujisaki T, Abe Y, Takamatsu Y, Yokota S, Akashi K, et al. Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study). Journal of Hematology & Oncology. 6: 14. PMID 23388549 DOI: 10.1186/1756-8722-6-14 |
0.409 |
|
| 2013 |
Uchida M, Ikesue H, Kato K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Egashira N, Akashi K, Oishi R. Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 70: 343-9. PMID 23370141 DOI: 10.2146/Ajhp120363 |
0.305 |
|
| 2013 |
Yamauchi T, Takenaka K, Urata S, Shima T, Kikushige Y, Tokuyama T, Iwamoto C, Nishihara M, Iwasaki H, Miyamoto T, Honma N, Nakao M, Matozaki T, Akashi K. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Blood. 121: 1316-25. PMID 23293079 DOI: 10.1016/J.Exphem.2013.05.136 |
0.333 |
|
| 2013 |
Ito Y, Miyamoto T, Chong Y, Aoki T, Kato K, Akashi K, Kamimura T. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplantation. 48: 998-9. PMID 23292237 DOI: 10.1038/Bmt.2012.268 |
0.404 |
|
| 2013 |
Muta T, Miyamoto T, Fujisaki T, Ohno Y, Kamimura T, Kato K, Takenaka K, Iwasaki H, Eto T, Takamatsu Y, Teshima T, Akashi K. Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma. Internal Medicine (Tokyo, Japan). 52: 63-70. PMID 23291675 DOI: 10.2169/Internalmedicine.52.8390 |
0.474 |
|
| 2013 |
Shima T, Miyamoto T, Kikushige Y, Mori Y, Kamezaki K, Takase K, Henzan H, Numata A, Ito Y, Takenaka K, Iwasaki H, Kamimura T, Eto T, Nagafuji K, Teshima T, et al. Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation. Blood. 121: 840-8. PMID 23233661 DOI: 10.1182/Blood-2012-02-409607 |
0.518 |
|
| 2013 |
Yokota N, Kamimura T, Aoki T, Ito Y, Muraoka H, Tsutsui R, Miyamoto T. The relationship between distress and prolonged hospitalization after allogeneic hematopoietic stem cell transplantation Journal of Hematopoietic Cell Transplantation. 2: 101-108. DOI: 10.7889/HCT.2.101 |
0.31 |
|
| 2013 |
Jo T, Ishida T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, Uike N, Saburi Y, Nosaka K, Utsunomiya A, Tobinai K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, ... ... Miyamoto T, et al. Randomized phase II study of mogamulizumab (KW-0761) plus VCAP-AMP-VECP (mLSG15) versus mLSG15 alone for newly diagnosed aggressive adult T-cell leukemia-lymphoma (ATL). Journal of Clinical Oncology. 31: 8506-8506. DOI: 10.1200/Jco.2013.31.15_Suppl.8506 |
0.312 |
|
| 2013 |
Takamatsu Y, Imamura Y, Nakazato T, Uike N, Miyashita K, Saburi Y, Harada N, Ota S, Imamura R, Miyamoto T. Once-Weekly Subcutaneous Bortezomib Plus Oral Cyclophosphamide and Dexamethasone Therapy For Relapsed Or Refractory Multiple Myeloma Blood. 122: 5382-5382. DOI: 10.1182/Blood.V122.21.5382.5382 |
0.331 |
|
| 2013 |
Yuda J, Miyamoto T, Kikushige Y, Odawara J, Ohkawa Y, Akashi K. The Impact Of Novel Splicing Abnormalities Of BCR-ABL On The Pathogenesis Of CML Blood. 122: 5159-5159. DOI: 10.1182/Blood.V122.21.5159.5159 |
0.318 |
|
| 2013 |
Kikushige Y, Yuda J, Shima T, Miyamoto T, Akashi K. TIM-3, a Leukemia Stem Cell Marker, Plays a Role In Leukemic Transformation Through Autocrine Stimulatory Signaling By Its Ligand, Galectin-9 Blood. 122: 4196-4196. DOI: 10.1182/Blood.V122.21.4196.4196 |
0.467 |
|
| 2013 |
Yamauchi T, Shima T, Takenaka K, Miyamoto T, Akashi K. Fibrotic Tissues In Human Primary Myelofibrosis With JAK2 V617F Are Developed Clonally From Malignant Hematopoietic Stem Cells Blood. 122: 4106-4106. DOI: 10.1182/Blood.V122.21.4106.4106 |
0.447 |
|
| 2013 |
Okamura T, Seki R, Nagafuji K, Nosaka K, Tsuchiya T, Tsuda H, Miyamoto T, Higuchi M, Suzushima H, Hidaka M, Yasunobu A, Yufu Y, Imamura Y, Iwahashi M, Fujisaki T, et al. Prognostic Significance Of S-Phase Kinase-Associated Protein 2 (Skp2) In DLBCL Patients Treated With Upfront Autologous Peripheral Blood Stem Cell Transplantation Blood. 122: 3022-3022. DOI: 10.1182/Blood.V122.21.3022.3022 |
0.438 |
|
| 2013 |
Yakushijin K, Atsuta Y, Noriko D, Yokota A, Kanamori H, Miyamoto T, Sakamaki H, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T. Nationwide Survey of Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome: On Behalf of Complications Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Blood. 122: 2051-2051. DOI: 10.1182/Blood.V122.21.2051.2051 |
0.402 |
|
| 2013 |
Miyawaki K, Kusumoto H, Iino T, Kohno K, Tsuzuki H, Shima T, Kikushige Y, Arinobu Y, Takenaka K, Miyamoto T, Iwasaki H, Akashi K. The Expansion Of CML Clones Initiates At The CMP Stage, and Is Associated With The Down-Regulation Of IRF8 and GFI1 Blood. 122: 1477-1477. DOI: 10.1182/Blood.V122.21.1477.1477 |
0.471 |
|
| 2013 |
Miyamoto T. AML stem cell The Japanese Journal of Clinical Hematology. 54: 1643-1650. DOI: 10.11406/Rinketsu.54.1643 |
0.413 |
|
| 2013 |
Tsukamoto H, Horiuchi T, Miyamoto T, Niiro H, Arinobu Y, Akahoshi M, Ayano M, Tanaka A, Ueda N, Akashi K. FRI0406 Seven-year follow-up of autologous hematopoietic stem cell transplantation for severe systemic sclerosis Annals of the Rheumatic Diseases. 72: A511.1-A511. DOI: 10.1136/Annrheumdis-2013-Eular.1533 |
0.491 |
|
| 2013 |
Tsukamoto H, Horiuchi T, Miyamoto T, Niiro H, Arinobu Y, Inoue Y, Ayano M, Tanaka A, Ueda N, Harada M, Akashi K. THU0238 Long-term follow-up of autologous hematopoietic stem cell transplantation for severe systemic sclerosis Annals of the Rheumatic Diseases. 71: 235.3-236. DOI: 10.1136/Annrheumdis-2012-Eular.2203 |
0.461 |
|
| 2013 |
Yuda J, Kato K, Takenaka K, Hayashi M, Urata S, Takashima S, Kikushige Y, Tanimoto K, Iwasaki H, Miyamoto T, Teshima T, Akashi K. Lenalidomide Could Minimize an Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation in Patients With POEMS Syndrome Biology of Blood and Marrow Transplantation. 19: S240-S241. DOI: 10.1016/J.Bbmt.2012.11.308 |
0.433 |
|
| 2013 |
Kato K, Miyamoto T, Eto Y, Yonemoto K, Yoshida S, Saito N, Henzan H, Ito Y, Yuda J, Hayashi M, Takashima S, Urata S, Kikushige Y, Oku S, Kuriyama T, et al. BK Virus Subtype III Is Associated with Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 19: S119-S120. DOI: 10.1016/J.Bbmt.2012.11.046 |
0.431 |
|
| 2012 |
Kuriyama T, Takenaka K, Kohno K, Yamauchi T, Daitoku S, Yoshimoto G, Kikushige Y, Kishimoto J, Abe Y, Harada N, Miyamoto T, Iwasaki H, Teshima T, Akashi K. Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood. 120: 4058-67. PMID 22990013 DOI: 10.1182/Blood-2012-02-408864 |
0.397 |
|
| 2012 |
Mori Y, Miyamoto T, Kamezaki K, Kato K, Kikushige Y, Takashima S, Urata S, Shimoda S, Shimono N, Takenaka K, Iwasaki H, Nagafuji K, Teshima T, Akashi K. Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era. American Journal of Hematology. 87: 828-30. PMID 22641349 DOI: 10.1002/Ajh.23247 |
0.467 |
|
| 2012 |
Takenaka K, Nagafuji K, Takase K, Kamimura T, Mori Y, Ito Y, Nishi Y, Henzan H, Kato K, Harada N, Eto T, Miyamoto T, Teshima T, Akashi K. Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. International Journal of Hematology. 96: 94-100. PMID 22547196 DOI: 10.1007/S12185-012-1087-9 |
0.426 |
|
| 2012 |
Kamimura T, Yong C, Ito Y, Henzan H, Miyamoto T, Ohno Y, Eto T, Takenaka K, Akashi K. [Clinical outcomes of allogeneic hematopoietic stem cell transplantation for adult primary myelofibrosis: retrospective analysis by Fukuoka BMT group]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 53: 323-8. PMID 22499049 |
0.386 |
|
| 2012 |
Kamimura T, Miyamoto T, Kawano N, Numata A, Ito Y, Chong Y, Nagafuji K, Teshima T, Hayashi S, Akashi K. Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 95: 725-30. PMID 22481502 DOI: 10.1007/S12185-012-1056-3 |
0.501 |
|
| 2012 |
Fuji S, Nakamura F, Hatanaka K, Taniguchi S, Sato M, Mori S, Sakamaki H, Yabe H, Miyamoto T, Kanamori H, Ueda Y, Kawa K, Kato K, Suzuki R, Atsuta Y, et al. Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 1407-14. PMID 22430086 DOI: 10.1016/J.Bbmt.2012.02.014 |
0.466 |
|
| 2012 |
Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 837-42. PMID 22312108 DOI: 10.1200/Jco.2011.37.3472 |
0.389 |
|
| 2012 |
Shiraishi A, Ohga S, Doi T, Ishimura M, Takimoto T, Takada H, Miyamoto T, Abe Y, Hara T. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer. 59: 265-70. PMID 22183955 DOI: 10.1002/Pbc.24039 |
0.416 |
|
| 2012 |
Mori Y, Teshima T, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Miyamoto T, Nagafuji K, Eto T, Akashi K. Validation of pretransplantation assessment of mortality risk score in the outcome of hematopoietic SCT in non-Caucasians. Bone Marrow Transplantation. 47: 1075-81. PMID 22101199 DOI: 10.1038/Bmt.2011.229 |
0.344 |
|
| 2012 |
Sugiyama A, Takeuchi S, Fukagawa S, Moroi Y, Yoshimoto G, Miyamoto T, Akashi K, Furue M. Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation. The Journal of Dermatology. 39: 172-5. PMID 21951268 DOI: 10.1111/J.1346-8138.2011.01309.X |
0.313 |
|
| 2012 |
Shima T, Kikushige Y, Miyamoto T, Akashi K. The First Demonstration of Sequential Acquisition of Class I and Class II Gene Mutations in Formation of Human Acute Myeloid Leukemia Stem Cells Blood. 120: 859-859. DOI: 10.1182/Blood.V120.21.859.859 |
0.399 |
|
| 2012 |
Ishida T, Ogura M, Hatake K, Taniwaki M, Ando K, Tobinai K, Fujimoto K, Yamamoto K, Miyamoto T, Uike N, Tanimoto M, Tsukasaki K, Ishizawa K, Suzumiya J, Inagaki H, et al. Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CCR4 Antibody, in Patients with Relapsed Peripheral and Cutaneous T-Cell Lymphoma Blood. 120: 795-795. DOI: 10.1182/Blood.V120.21.795.795 |
0.404 |
|
| 2012 |
Kikushige Y, Shima T, Yuda J, Miyamoto T, Akashi K. Leukemogenic Function of TIM-3, a Leukemia Stem Cell Marker, in Acute Myelogenous Leukemia and Myelodysplastic Syndromes. Blood. 120: 2983-2983. DOI: 10.1182/Blood.V120.21.2983.2983 |
0.482 |
|
| 2012 |
Yamauchi T, Takenaka K, Urata S, Shima T, Kikushige Y, Tokuyama T, Iwamoto C, Miyamoto T, Akashi K. Establishment of a New Immunodeficient Mouse Line Harboring NOD-Type Sirpa with Highly-Efficient Human Hematopoietic Cell Engraftment. Blood. 120: 2301-2301. DOI: 10.1182/Blood.V120.21.2301.2301 |
0.422 |
|
| 2012 |
Takamatsu Y, Sunami K, Miyamoto T, Hata H, Muta T, Tsukada J, Uozumi K, Tamura K. Bortezomib in Combination with Cytotoxic Agent Therapy for Multiple Myeloma Annals of Oncology. 23. DOI: 10.1016/S0923-7534(20)32190-6 |
0.324 |
|
| 2011 |
Mori Y, Miyawaki K, Kato K, Takenaka K, Iwasaki H, Harada N, Miyamoto T, Akashi K, Teshima T. Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting. Internal Medicine (Tokyo, Japan). 50: 2149-55. PMID 21963733 DOI: 10.2169/Internalmedicine.50.5798 |
0.421 |
|
| 2011 |
Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 20: 246-59. PMID 21840488 DOI: 10.1016/J.Ccr.2011.06.029 |
0.428 |
|
| 2011 |
Mori Y, Miyamoto T, Kato K, Kamezaki K, Kuriyama T, Oku S, Takenaka K, Iwasaki H, Harada N, Shiratsuchi M, Abe Y, Nagafuji K, Teshima T, Akashi K. Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 458-65. PMID 21810401 DOI: 10.1016/J.Bbmt.2011.07.025 |
0.418 |
|
| 2011 |
Kamimura T, Miyamoto T, Harada M, Akashi K. Advances in therapies for acute promyelocytic leukemia. Cancer Science. 102: 1929-37. PMID 21790894 DOI: 10.1111/J.1349-7006.2011.02045.X |
0.42 |
|
| 2011 |
Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 51: 31-7. PMID 21377409 DOI: 10.1016/J.Jcv.2011.01.014 |
0.31 |
|
| 2011 |
Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, Iwasaki H, Takenaka K, Teshima T, Tanaka T, Inagaki Y, Akashi K. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell. 7: 708-17. PMID 21112565 DOI: 10.1016/J.Stem.2010.11.014 |
0.436 |
|
| 2011 |
Aoki T, Miyamoto T, Mori Y, Yoshimoto G, Yamauchi T, Kamezaki K, Takenaka K, Iwasaki H, Harada N, Nagafuji K, Shimono N, Teshima T, Akashi K. Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy. Mycoses. 54: e255-9. PMID 20236243 DOI: 10.1111/J.1439-0507.2010.01858.X |
0.454 |
|
| 2011 |
Miyamoto T, Kikushige Y, Shima T, Akashi K. TIM-3 Is a Promising Target to Eradicate Acute Myeloid Leukemia Stem Cells Sparing Normal Hematopoietic Stem Cells Blood. 118: 559-559. DOI: 10.1182/Blood.V118.21.559.559 |
0.496 |
|
| 2011 |
Kuriyama T, Takenaka K, Kohno K, Yoshimoto G, Kishimoto J, Abe Y, Miyamoto T, Akashi K. Hemophagocytic Lymphohistiocytosis Is Caused by Engulfment of Hematopoietic Stem Cells by Macrophages Through Stem Cell-Specific Suppression of CD47 Under Influence of Cytokine Deregulation Blood. 118: 522-522. DOI: 10.1182/Blood.V118.21.522.522 |
0.368 |
|
| 2011 |
Takamatsu Y, Sunami K, Muta T, Tsukada J, Miyamoto T, Eto T, Higuchi M, Hata H, Suzumiya J, Tamura K. A Phase I/II Study of Bortezomib in Combination with Doxorubicin and Intermediate-Dose Dexamethasone (iPAD therapy) for Relapsed or Refractory Multiple Myeloma Blood. 118: 5137-5137. DOI: 10.1182/Blood.V118.21.5137.5137 |
0.328 |
|
| 2011 |
Iwamoto C, Takenaka K, Urata S, Shima T, Itoh K, Kishimoto J, Miyamoto T, Matozaki T, Akashi K. The Efficient Engraftment of Human Hematopoiesis in the Balb/c Strain Is Mounted by Balb/c-Specific SIRPA Polymorphism That Enhances Binding Affinity to Human CD47, Blood. 118: 4008-4008. DOI: 10.1182/Blood.V118.21.4008.4008 |
0.323 |
|
| 2011 |
Seki R, Arakawa F, Yasuda K, Doi A, Miyamoto T, Akashi K, Ohshima K, Okamura T. DNA Microarray Analysis in DLBCL Dependent on Skp2 Expression, Blood. 118: 3695-3695. DOI: 10.1182/Blood.V118.21.3695.3695 |
0.341 |
|
| 2011 |
Shima T, Kikushige Y, Miyamoto T, Akashi K. Sequential Acquisition of AML1-ETO and c-Kit Mutation Leads to Formation of Human t(8;21) Acute Myelogenous Leukemia Stem Cells, Blood. 118: 3584-3584. DOI: 10.1182/Blood.V118.21.3584.3584 |
0.412 |
|
| 2011 |
Nagafuji K, Miyamoto T, Eto T, Kamimura T, Taniguchi S, Okamura T, Ohtsuka E, Yoshida T, Higuchi M, Yoshimoto G, Fujisaki T, Abe Y, Takamatsu Y, Yokota S, Akashi K, et al. Minimal Residual Disease Negative Status At the End of Induction Therapy Is a Potent Prognostic Marker in Adult Non-Ph Acute Lymphoblastic Leukemia: Results of the ALL MRD2002 Study Blood. 118: 2581-2581. DOI: 10.1182/Blood.V118.21.2581.2581 |
0.307 |
|
| 2011 |
Kamimura T, Miyamoto T, Ohno Y, Eto T, Akashi K. 331 Clinical outcomes of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome: retrospective analysis of Fukuoka BMT group Leukemia Research. 35: S132-S133. DOI: 10.1016/S0145-2126(11)70333-2 |
0.427 |
|
| 2010 |
Tsukamoto H, Nagafuji K, Horiuchi T, Mitoma H, Niiro H, Arinobu Y, Inoue Y, To K, Miyamoto T, Iwasaki H, Teshima T, Harada M, Akashi K. Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells. Rheumatology (Oxford, England). 50: 944-52. PMID 21172925 DOI: 10.1093/Rheumatology/Keq414 |
0.457 |
|
| 2010 |
Kamimura T, Miyamoto T, Nagafuji K, Numata A, Henzan H, Takase K, Ito Y, Ohno Y, Fujisaki T, Eto T, Takamatsu Y, Teshima T, Gondo H, Akashi K, Taniguchi S, et al. Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review. Bone Marrow Transplantation. 46: 820-6. PMID 20818443 DOI: 10.1038/Bmt.2010.207 |
0.333 |
|
| 2010 |
Kikushige Y, Miyamoto T, Akashi K. [Hematopoietic stem cells are primarily involved in pathogenesis of chronic lymphocytic leukemia]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 51: 679-84. PMID 20805675 |
0.325 |
|
| 2010 |
Miyamoto T. [Autologous peripheral blood stem cell transplantation as a treatment choice for adult acute myelogenous leukemia]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 51: 477-83. PMID 20693766 |
0.352 |
|
| 2010 |
Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, Saito N, Kato K, Takenaka K, Iwasaki H, Harada N, Abe Y, Teshima T, Akashi K. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1596-602. PMID 20685258 DOI: 10.1016/J.Bbmt.2010.05.009 |
0.439 |
|
| 2010 |
Nishida R, Mori Y, Iwasaki H, Tokuyama T, Kamezaki K, Nagasaki Y, Oka H, Miyawaki K, Saito N, Takenaka K, Harada N, Miyamoto T, Teshima T, Akashi K. Pulmonary nocardiosis developed in a hematopoietic stem cell transplant recipient with bronchiolitis obliterans. Internal Medicine (Tokyo, Japan). 49: 1441-4. PMID 20647664 DOI: 10.2169/Internalmedicine.49.3658 |
0.447 |
|
| 2010 |
Oku S, Takenaka K, Kuriyama T, Shide K, Kumano T, Kikushige Y, Urata S, Yamauchi T, Iwamoto C, Shimoda HK, Miyamoto T, Nagafuji K, Kishimoto J, Shimoda K, Akashi K. JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation. British Journal of Haematology. 150: 334-44. PMID 20553273 DOI: 10.1111/J.1365-2141.2010.08249.X |
0.302 |
|
| 2010 |
Mori Y, Nagasaki Y, Kamezaki K, Takenaka K, Iwasaki H, Harada N, Miyamoto T, Abe Y, Shimono N, Akashi K, Teshima T. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. American Journal of Hematology. 85: 449-51. PMID 20513124 DOI: 10.1002/Ajh.21697 |
0.44 |
|
| 2010 |
Aoki T, Kamezaki K, Miyamoto T, Nagafuji K, Mori Y, Yamauchi T, Takenaka K, Iwasaki H, Harada N, Shimono N, Teshima T, Akashi K. Cord blood stem cell transplantation in a patient with disseminated mucormycosis and acute myelogenous leukemia. Transplant Infectious Disease : An Official Journal of the Transplantation Society. 12: 277-9. PMID 20180927 DOI: 10.1111/J.1399-3062.2010.00496.X |
0.387 |
|
| 2010 |
Nagae H, Sato Y, Yoshitomi R, Ago T, Taniguchi M, Masutani K, Miyamoto T, Tsuruya K, Iida M. A Case of Radiation Nephropathy after Stem Cell Transplantation. Nihon Naika Gakkai Zasshi. 99: 1907-1909. DOI: 10.2169/Naika.99.1907 |
0.404 |
|
| 2010 |
Kikushige Y, Ishikawa F, Miyamoto T, Akashi K. Hematopoietic Stem Cells Are Primarily Involved In Pathogenesis of Chronic Lymphocytic Leukemia. Blood. 116: 4604-4604. DOI: 10.1182/Blood.V116.21.4604.4604 |
0.467 |
|
| 2010 |
Uchida N, Hidaka M, Sakura T, Miyamoto T, Fujisaki T, Eto T, Maeda Y, Fukuno K, Matsumoto K, Morita K, Kishimoto J, Fukuda T, Teshima T, Taniguchi S, Mori S, et al. Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study. Blood. 116: 3477-3477. DOI: 10.1182/Blood.V116.21.3477.3477 |
0.456 |
|
| 2010 |
Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, et al. Multicenter Phase II Study of KW-0761, a Defucosylated Anti-CCR4 Antibody, In Relapsed Patients with Adult T-Cell Leukemia-Lymphoma (ATL) Blood. 116: 285-285. DOI: 10.1182/Blood.V116.21.285.285 |
0.395 |
|
| 2010 |
Shima T, Kikushige Y, Miyamoto T, Akashi K. Identification of Human Monocyte Lineage Progenitors Lacking Granulocyte Potential: Revision of Phenotypic Definition of Human GMP. Blood. 116: 1614-1614. DOI: 10.1182/Blood.V116.21.1614.1614 |
0.367 |
|
| 2010 |
Ohga S, Ishimura M, Toshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Imadome K, Abe Y, Akashi K, Hara T. Clonal origin of Epstein-Barr virus-infected T/NK-cell subpopulations in chronic active Epstein-Barr virus infection Nature Precedings. 5: 1-1. DOI: 10.1038/Npre.2010.4238.1 |
0.396 |
|
| 2009 |
Mori Y, Aoki T, Takenaka K, Yamauchi T, Yamamoto A, Kamezaki K, Iwasaki H, Harada N, Miyamoto T, Nagafuji K, Teshima T, Akashi K. Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation. International Journal of Hematology. 91: 107-11. PMID 19949902 DOI: 10.1007/S12185-009-0453-8 |
0.457 |
|
| 2009 |
Yoshimoto G, Miyamoto T, Jabbarzadeh-Tabrizi S, Iino T, Rocnik JL, Kikushige Y, Mori Y, Shima T, Iwasaki H, Takenaka K, Nagafuji K, Mizuno S, Niiro H, Gilliland GD, Akashi K. FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation. Blood. 114: 5034-43. PMID 19808698 DOI: 10.1182/Blood-2008-12-196055 |
0.433 |
|
| 2009 |
Yamauchi T, Mori Y, Miyamoto T, Kamezaki K, Aoki T, Yamamoto A, Takenaka K, Iwasaki H, Harada N, Nagafuji K, Teshima T, Akashi K. Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia. International Journal of Hematology. 90: 416-420. PMID 19697098 DOI: 10.1007/S12185-009-0405-3 |
0.472 |
|
| 2009 |
Abe Y, Ito T, Baba E, Nagafuji K, Kawabe K, Choi I, Arita Y, Miyamoto T, Teshima T, Nakano S, Harada M. Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer. Pancreas. 38: 815-9. PMID 19696692 DOI: 10.1097/Mpa.0B013E3181B576Ee |
0.445 |
|
| 2009 |
Matsuo Y, Kamezaki K, Takeishi S, Takenaka K, Eto T, Nonami A, Miyamoto T, Iwasaki H, Harada N, Nagafuji K, Teshima T, Akashi K. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Internal Medicine. 48: 1453-1456. PMID 19687597 DOI: 10.2169/Internalmedicine.48.2003 |
0.39 |
|
| 2009 |
Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, et al. Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group. Bone Marrow Transplantation. 45: 311-6. PMID 19597416 DOI: 10.1038/Bmt.2009.165 |
0.473 |
|
| 2009 |
Teshima T, Nagafuji K, Henzan H, Miyamura K, Takase K, Hidaka M, Miyamoto T, Takenaka K, Akashi K, Harada M. Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease. International Journal of Hematology. 90: 253-60. PMID 19543951 DOI: 10.1007/S12185-009-0370-X |
0.407 |
|
| 2009 |
Nagasaki Y, Miyamoto T, Henzan H, Nagafuji K, Harada M, Akashi K. Longstanding remission of adult onset Still's disease under imatinib therapy in a patient with chronic myelogenous leukemia. The Journal of Rheumatology. 36: 1349-51. PMID 19509096 DOI: 10.3899/Jrheum.081159 |
0.336 |
|
| 2009 |
Kohno K, Nagafuji K, Tsukamoto H, Horiuchi T, Takase K, Aoki K, Henzan H, Kamezaki K, Takenaka K, Miyamoto T, Teshima T, Harada M, Akashi K. Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Transplant Infectious Disease : An Official Journal of the Transplantation Society. 11: 318-23. PMID 19453993 DOI: 10.1111/J.1399-3062.2009.00401.X |
0.45 |
|
| 2009 |
Tabrizi SJ, Niiro H, Masui M, Yoshimoto G, Iino T, Kikushige Y, Wakasaki T, Baba E, Shimoda S, Miyamoto T, Hara T, Akashi K. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. Journal of Immunology (Baltimore, Md. : 1950). 182: 1490-9. PMID 19155496 DOI: 10.4049/Jimmunol.182.3.1490 |
0.332 |
|
| 2009 |
Takenaka K, Eto T, Nagafuji K, Kamezaki K, Matsuo Y, Yoshimoto G, Harada N, Yoshida M, Henzan H, Takase K, Miyamoto T, Akashi K, Harada M, Teshima T. Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. International Journal of Hematology. 89: 231-7. PMID 19148587 DOI: 10.1007/S12185-008-0249-2 |
0.447 |
|
| 2009 |
Shima T, Yoshimoto G, Miyamoto T, Yoshida S, Kamezaki K, Takenaka K, Iwasaki H, Harada N, Nagafuji K, Teshima T, Shimono N, Akashi K. Disseminated tuberculosis following second unrelated cord blood transplantation for acute myelogenous leukemia. Transplant Infectious Disease : An Official Journal of the Transplantation Society. 11: 75-7. PMID 19000153 DOI: 10.1111/J.1399-3062.2008.00354.X |
0.372 |
|
| 2009 |
Nagafuji K, Aoki K, Henzan H, Kato K, Miyamoto T, Eto T, Nagatoshi Y, Ohba T, Obama K, Gondo H, Harada M. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation. 34: 909-14. PMID 15361907 DOI: 10.1038/Sj.Bmt.1704682 |
0.434 |
|
| 2009 |
Shima T, Miyamoto T, Kikushige Y, Kamezaki K, Takenaka K, Teshima T, Akashi K. Predominant Reconstitution of B Lymphoid Precursors (hematogones) Following Cord Blood Stem Cell Transplantation Is Associated with Less Occurrence of Acute Graft-Versus-Host Disease and Superior Overall Survival. Blood. 114: 2231-2231. DOI: 10.1182/Blood.V114.22.2231.2231 |
0.491 |
|
| 2009 |
Oku S, Takenaka K, Shide K, Kumano T, Yoshikane K, Kuriyama T, Urata S, Iwamoto C, Yamauchi T, Shimoda H, Miyamoto T, Shimoda K, Akashi K. JAK2V617F Mutation Selectively Exerts the STAT3 Pathway for Enhancing a Neutrophil Activation Marker. Blood. 114: 1901-1901. DOI: 10.1182/Blood.V114.22.1901.1901 |
0.338 |
|
| 2008 |
Mori Y, Iwasaki H, Kohno K, Yoshimoto G, Kikushige Y, Okeda A, Uike N, Niiro H, Takenaka K, Nagafuji K, Miyamoto T, Harada M, Takatsu K, Akashi K. Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor. The Journal of Experimental Medicine. 206: 183-93. PMID 19114669 DOI: 10.1084/Jem.20081756 |
0.334 |
|
| 2008 |
Aoki T, Miyamoto T, Yoshida S, Yamamoto A, Yamauchi T, Yoshimoto G, Mori Y, Kamezaki K, Iwasaki H, Takenaka K, Harada N, Nagafuji K, Teshima T, Akashi K. Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9. International Journal of Hematology. 88: 571-574. PMID 19005624 DOI: 10.1007/S12185-008-0198-9 |
0.366 |
|
| 2008 |
Shima T, Yoshimoto G, Nonami A, Yoshida S, Kamezaki K, Iwasaki H, Takenaka K, Miyamoto T, Harada N, Teshima T, Akashi K, Nagafuji K. Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient. International Journal of Hematology. 88: 336-340. PMID 18712461 DOI: 10.1007/S12185-008-0148-6 |
0.402 |
|
| 2008 |
Tatsugami K, Eto M, Harano M, Hamaguchi M, Miyamoto T, Morisaki T, Furue M, Akashi K, Naito S. Dendritic cell therapy in combination with interferon‐α for the treatment of metastatic renal cell carcinoma International Journal of Urology. 15: 694-698. PMID 18564205 DOI: 10.1111/J.1442-2042.2008.02088.X |
0.316 |
|
| 2008 |
Kikushige Y, Yoshimoto G, Miyamoto T, Iino T, Mori Y, Iwasaki H, Niiro H, Takenaka K, Nagafuji K, Harada M, Ishikawa F, Akashi K. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival. Journal of Immunology (Baltimore, Md. : 1950). 180: 7358-67. PMID 18490735 DOI: 10.4049/Jimmunol.180.11.7358 |
0.445 |
|
| 2008 |
Oku S, Takenaka K, Kumano T, Kuriyama T, Urata S, Shide K, Shimoda H, Iwasaki H, Miyamoto T, Teshima T, Nagafuji K, Shimoda K, Akashi K. Elevated Leukocyte Alkaline Phosphatase Scores Induced by Jak2 V617F Mutation Blood. 112: 5244-5244. DOI: 10.1182/Blood.V112.11.5244.5244 |
0.317 |
|
| 2008 |
Shima T, Miyamoto T, Kikushige Y, Nagafuji K, Teshima T, Akashi K. Predominant Reconstitution of B Lymphoid Precursors (Hematogones) Following Unrelated Cord Blood Stem Cell Transplantation. Blood. 112: 2199-2199. DOI: 10.1182/Blood.V112.11.2199.2199 |
0.478 |
|
| 2007 |
Nonami A, Miyamoto T, Kuroiwa M, Kunisaki Y, Kamezaki K, Takenaka K, Harada N, Teshima T, Harada M, Nagafuji K. Successful treatment of primary plasma cell leukaemia by allogeneic stem cell transplantation from haploidentical sibling. Japanese Journal of Clinical Oncology. 37: 969-72. PMID 18055567 DOI: 10.1093/Jjco/Hym130 |
0.478 |
|
| 2007 |
Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, Fukata M, Miyamoto T, Lyons B, Ohshima K, Uchida N, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nature Biotechnology. 25: 1315-21. PMID 17952057 DOI: 10.1038/Nbt1350 |
0.459 |
|
| 2007 |
Nonami A, Takenaka K, Sumida C, Aizawa K, Kamezaki K, Miyamoto T, Harada N, Nagafuji K, Teshima T, Harada M. Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantation. Internal Medicine (Tokyo, Japan). 46: 1753-6. PMID 17938534 DOI: 10.2169/Internalmedicine.46.0291 |
0.337 |
|
| 2007 |
Kamezaki K, Miyamoto T, Henzan T, Numata A, Iwasaki H, Nagafuji K, Harada M, Teshima T, Akashi K. Collection of mobilized peripheral blood stem cells from a donor with severe iron deficient anemia. Journal of Clinical Apheresis. 22: 292-294. PMID 17703461 DOI: 10.1002/Jca.20141 |
0.324 |
|
| 2007 |
Matsuo Y, Takeishi S, Miyamoto T, Nonami A, Kikushige Y, Kunisaki Y, Kamezaki K, Tu L, Hisaeda H, Takenaka K, Harada N, Kamimura T, Ohno Y, Eto T, Teshima T, et al. Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. European Journal of Haematology. 79: 317-21. PMID 17680814 DOI: 10.1111/J.1600-0609.2007.00919.X |
0.475 |
|
| 2007 |
Ishikawa F, Niiro H, Iino T, Yoshida S, Saito N, Onohara S, Miyamoto T, Minagawa H, Fujii S, Shultz LD, Harada M, Akashi K. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood. 110: 3591-660. PMID 17664352 DOI: 10.1182/Blood-2007-02-071613 |
0.372 |
|
| 2007 |
Kikushige Y, Takase K, Sata K, Aoki K, Numata A, Miyamoto T, Fukuda T, Gondo H, Harada M, Nagafuji K. Repeated relapses of acute myelogenous leukemia in the isolated extramedullary sites following allogeneic bone marrow transplantations. Internal Medicine (Tokyo, Japan). 46: 1011-4. PMID 17603242 DOI: 10.2169/Internalmedicine.46.6384 |
0.439 |
|
| 2007 |
Mori Y, Yoshimoto G, Kumano T, Miyamoto T, Iino T, Takenaka K, Iwasaki H, Harada N, Kinukawa N, Nagafuji K, Teshima T, Shimoda K, Akashi K, Harada M. Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation. European Journal of Haematology. 79: 17-24. PMID 17598835 DOI: 10.1111/J.1600-0609.2007.00866.X |
0.322 |
|
| 2007 |
Nonami A, Takenaka K, Kamezaki K, Miyamoto T, Harada N, Nagafuji K, Teshima T, Harada M. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation. International Journal of Hematology. 85: 264-6. PMID 17483065 DOI: 10.1532/Ijh97.06197 |
0.428 |
|
| 2007 |
Kamezaki K, Kikushige Y, Numata A, Miyamoto T, Takase K, Henzan H, Aoki K, Kato K, Nonami A, Kamimura T, Arima F, Takenaka K, Harada N, Fukuda T, Hayashi S, et al. Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma. Bone Marrow Transplantation. 39: 523-7. PMID 17369863 DOI: 10.1038/Sj.Bmt.1705649 |
0.477 |
|
| 2007 |
Saito Y, Yoshida S, Saito N, Fukata M, Ozawa H, Doi T, Miyamoto T, Ohshima K, Uchida N, Taniguchi S, Akashi K, Harada M, Shultz LD, Ishikawa F. Human AML Stem Cells Remain Quiescent and Exhibit Chemotherapy Resistance within the Bone Marrow Endosteal Region. Blood. 110: 780-780. DOI: 10.1182/Blood.V110.11.780.780 |
0.469 |
|
| 2007 |
Kikushige Y, Yoshimoto G, Miyamoto T, Ishikawa F, Iwasaki H, Akashi K. Human FLT3/FLK2 Targets Hematopoietic Stem Cells and Granulocyte/Macrophage Progenitors. Blood. 110: 1263-1263. DOI: 10.1182/Blood.V110.11.1263.1263 |
0.391 |
|
| 2007 |
Koyama M, Hashimoto D, Kamezaki K, Numata A, Sakoda Y, Aoyama K, Takenaka K, Miyamoto T, Harada N, Nagafuji K, Akashi K, Tanimoto M, Harada M, Teshima T. 351: Early recovery of host T cells predicts primary graft rejection following non-myeloablative conditioning allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation. 13: 127. DOI: 10.1016/J.Bbmt.2006.12.356 |
0.446 |
|
| 2006 |
Kikushige Y, Takase K, Miyamoto T, Numata A, Kamesaki K, Fukuda T, Nagafuji K, Gondo H, Harada M. Late relapse of acute myelogenous leukemia followed by epstein-barr virus-associated lymphoproliferative disease 11 years after allogeneic bone marrow transplantation. International Journal of Hematology. 84: 441-4. PMID 17189227 DOI: 10.1532/Ijh97.06113 |
0.464 |
|
| 2006 |
Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, Harada M. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. American Journal of Hematology. 81: 59-61. PMID 16369976 DOI: 10.1002/Ajh.20462 |
0.325 |
|
| 2006 |
Yoshimoto G, Nagafuji K, Miyamoto T, Kinukawa N, Takase K, Eto T, Kato K, Hayashi S, Kamimura T, Ohno Y, Taniguchi S, Harada M. FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation. 36: 977-83. PMID 16184177 DOI: 10.1182/Blood.V104.11.1873.1873 |
0.425 |
|
| 2006 |
Kikushige Y, Yoshimoto G, Miyamoto T, Ishikawa F, Iwasaki H, Harada M, Akashi K. hFlt3 Expression Marks Long-Term Hematopoietic Stem Cells, but Not the Pathway Common to Granulocyte/Monocyte and Lymphoid Lineages in Human Hematopoiesis. Blood. 108: 1654-1654. DOI: 10.1182/Blood.V108.11.1654.1654 |
0.398 |
|
| 2006 |
Mori Y, Iwasaki H, Yoshimoto G, Okeda A, Miyamoto T, Mizuno S, Harada M, Takatsu K, Akashi K. Prospective Isolation of Human Eosinophil-Committed Progenitors. Blood. 108: 1285-1285. DOI: 10.1182/Blood.V108.11.1285.1285 |
0.323 |
|
| 2006 |
Yoshimoto G, Miyamoto T, Iino T, Kikushige Y, Niiro H, Iwasaki H, Harada M, Akashi K. Anti-Apoptotic MCL-1 Plays a Critical Role in Maintenance of Normal and Malignant Human Hematopoietic Stem Cells through FLT3 Signaling. Blood. 108: 11-11. DOI: 10.1182/Blood.V108.11.11.11 |
0.426 |
|
| 2006 |
Nagafuji K, Tsukamoto H, Numata A, Miyamoto T, Harada M. Viral infections during CD34+ cells purified autologous peripheral blood stem cell transplantation for the treatment of refractory autoimmune diseases Biology of Blood and Marrow Transplantation. 12: 91. DOI: 10.1016/J.Bbmt.2005.11.280 |
0.452 |
|
| 2005 |
Miyamoto T, Akashi K. Lineage promiscuous expression of transcription factors in normal hematopoiesis. International Journal of Hematology. 81: 361-7. PMID 16158815 DOI: 10.1532/Ijh97.05003 |
0.406 |
|
| 2005 |
Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, Henzan H, Himeji D, Koyama T, Miyake K, Inoue Y, Nakashima H, Otsuka T, Tanaka Y, Nagasawa K, et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Annals of the Rheumatic Diseases. 65: 508-14. PMID 16126798 DOI: 10.1136/Ard.2005.037879 |
0.424 |
|
| 2005 |
Imamura R, Miyamoto T, Yoshimoto G, Kamezaki K, Ishikawa F, Henzan H, Kato K, Takase K, Numata A, Nagafuji K, Okamura T, Sata M, Harada M, Inaba S. Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor. Journal of Immunology (Baltimore, Md. : 1950). 175: 2647-54. PMID 16081841 DOI: 10.4049/Jimmunol.175.4.2647 |
0.415 |
|
| 2005 |
Numata A, Yasuda K, Fukuda T, Baba E, Yamasaki S, Takase K, Miyamoto T, Nagafuji K, Nakano S, Harada M. Non-myeloablative allogeneic haemopoietic stem-cell transplantation for treatment of metastatic invasive thymoma. The Lancet. Oncology. 6: 626-8. PMID 16054574 DOI: 10.1016/S1470-2045(05)70285-0 |
0.459 |
|
| 2005 |
Kawano N, Ishikawa F, Shimoda K, Yasukawa M, Nagafuji K, Miyamoto T, Baba E, Tanaka T, Yamasaki S, Gondo H, Otsuka T, Ohshima K, Shultz LD, Akashi K, Harada M. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice. Leukemia. 19: 1384-90. PMID 15959532 DOI: 10.1038/Sj.Leu.2403829 |
0.351 |
|
| 2005 |
Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood. 106: 1565-73. PMID 15920010 DOI: 10.1182/Blood-2005-02-0516 |
0.448 |
|
| 2005 |
Tanimoto TE, Hirano A, Nagafuji K, Yamasaki S, Hashiguchi M, Okamura T, Kamezaki K, Takase K, Numata A, Miyamoto T, Fukuda T, Harada M. Mismatched unrelated cord blood transplantation in a patient with T-cell prolymphocytic leukemia. Leukemia. 19: 679-81. PMID 15690068 DOI: 10.1038/Sj.Leu.2403669 |
0.429 |
|
| 2005 |
Sada E, Henzan H, Ohtani R, Takase K, Miyamoto T, Fukuda T, Nagafuji K, Yamauchi K, Takamatsu Y, Inaba S, Harada M. Conditioning with targeted busulfan for autologous peripheral blood stem cells transplantation for acute myelogenous leukemia in an XYY male. American Journal of Hematology. 78: 55-8. PMID 15609287 DOI: 10.1002/Ajh.20255 |
0.462 |
|
| 2005 |
Muta T, Kamo M, Gondo H, Kato K, Eto T, Shibuya T, Fukuda T, Miyamoto T, Nagafuji K, Ichinohe T, Harada M. Human herpesvirus-6 encephalitis followed by severe acute GVHD after a stem cell transplant from a microchimeric non-inherited maternal antigen (NIMA)-mismatched sibling. Bone Marrow Transplantation. 35: 411-3. PMID 15608657 DOI: 10.1038/Sj.Bmt.1704770 |
0.457 |
|
| 2005 |
Isobe T, Tanimoto TE, Nakaji G, Miyamoto T, Yamasaki S, Takase K, Numata A, Fukuda T, Nagafuji K, Inaba S, Harada M. Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma. Bone Marrow Transplantation. 35: 315-6. PMID 15568035 DOI: 10.1038/Sj.Bmt.1704750 |
0.455 |
|
| 2005 |
Ishikawa F, Iino T, Niiro H, Yoshida S, Miyamoto T, Shigematsu H, Shultz LD, Harada M, Akashi K. Human Conventional and Plasmacytoid Dendritic Cells Can Originate from Both Lymphoid and Myeloid Progenitors in a New Humanized Mouse System. Blood. 106: 2273-2273. DOI: 10.1182/Blood.V106.11.2273.2273 |
0.327 |
|
| 2005 |
Yoshida S, Ishikawa F, Yasukawa M, Miyamoto T, Yoshimoto G, Kawano N, Shimoda K, Akashi K, Shultz LD, Harada M. Long-Term Engraftment and Self-Renewal of AML Stem Cells in the Newborn NOD-scid/IL2rgnull Immunodeficient Mouse Model. Blood. 106: 1261-1261. DOI: 10.1182/Blood.V106.11.1261.1261 |
0.482 |
|
| 2005 |
Nagafuji K, Miyamoto T, Fukuda T, Tsukamoto H, Horiuchi T, Harada M. CD34+ cells purified autologous peripheral blood stem cell transplantation for the treatment of refractory autoimmune diseases Biology of Blood and Marrow Transplantation. 11: 64. DOI: 10.1016/J.Bbmt.2004.12.190 |
0.466 |
|
| 2004 |
Gondo H, Himeji D, Kamezaki K, Numata A, Tanimoto T, Takase K, Aoki K, Henzan H, Nagafuji K, Miyamoto T, Ishikawa F, Shimoda K, Inaba S, Tsukamoto H, Horiuchi T, et al. Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation. International Journal of Hematology. 80: 441-8. PMID 15646657 DOI: 10.1532/Ijh97.04109 |
0.48 |
|
| 2004 |
Ohtsubo K, Takase K, Nagafuji K, Henzan H, Tanimoto T, Fukuda T, Miyamoto T, Inaba S, Harada M. Nonmyeloablative allogeneic bone marrow transplantation for treatment of myelodysplastic syndrome complicated by recent intracerebral hemorrhage. American Journal of Hematology. 77: 400-4. PMID 15558806 DOI: 10.1002/Ajh.20213 |
0.389 |
|
| 2004 |
Ishikawa F, Yasukawa M, Yoshida S, Nakamura K, Nagatoshi Y, Kanemaru T, Shimoda K, Shimoda S, Miyamoto T, Okamura J, Shultz LD, Harada M. Human cord blood- and bone marrow-derived CD34+ cells regenerate gastrointestinal epithelial cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1958-60. PMID 15467008 DOI: 10.1096/Fj.04-2396Fje |
0.45 |
|
| 2004 |
Henzan H, Yoshimoto G, Okeda A, Nagasaki Y, Hirano G, Takase K, Tanimoto T, Miyamoto T, Fukuda T, Nagafuji K, Harada M. Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia. Annals of Hematology. 83: 784-8. PMID 15322764 DOI: 10.1007/S00277-004-0932-1 |
0.348 |
|
| 2004 |
Uchino K, Sameshima H, Miyamoto T, Iino T, Kato K, Henzan H, Aoki K, Nagafuji K, Gondo H, Harada M. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab. Internal Medicine. 43: 131-134. PMID 15005256 DOI: 10.2169/Internalmedicine.43.131 |
0.366 |
|
| 2004 |
Miyamoto T, Shinozuka T, Maeda H, Hirasawa T, Muramatsu T, Murakami M, Makino T, Itagaki H, Nakamura Y. Effect of peripheral blood progenitor cell dose on hematopoietic recovery: identification of minimal progenitor cell requirements for rapid engraftment. Bone Marrow Transplantation. 33: 589-95. PMID 14743198 DOI: 10.1038/sj.bmt.1704412 |
0.368 |
|
| 2004 |
Nozoe M, Iino T, Nagafuji K, Miyamoto T, Ito H, Gondo H, Harada M. Influenza-induced rhabdomyolysis after autologous peripheral blood stem cell transplantation for malignant lymphoma. Internal Medicine (Tokyo, Japan). 42: 1127-30. PMID 14686755 DOI: 10.2169/Internalmedicine.42.1127 |
0.372 |
|
| 2003 |
Kawano N, Gondo H, Kamimura T, Aoki K, Iino T, Ishikawa F, Miyamoto T, Nagafuji K, Shimoda K, Hayashi S, Otsuka T, Kazuyama Y, Harada M. Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. International Journal of Hematology. 78: 370-3. PMID 14686497 DOI: 10.1007/Bf02983564 |
0.432 |
|
| 2003 |
Aoki K, Shimoda K, Oritani K, Matsuda T, Kamezaki K, Muromoto R, Numata A, Tamiya S, Haro T, Ishikawa F, Takase K, Yamamoto T, Yumioka T, Miyamoto T, Nagafuji K, et al. Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx. Experimental Hematology. 31: 1317-22. PMID 14662340 DOI: 10.1016/J.Exphem.2003.08.011 |
0.315 |
|
| 2003 |
Yamasaki S, Henzan H, Ohno Y, Yamanaka T, Iino T, Itou Y, Kuroiwa M, Maeda M, Kawano N, Kinukawa N, Miyamoto T, Nagafuji K, Shimoda K, Inaba S, Hayashi S, et al. Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors. Bone Marrow Transplantation. 32: 505-10. PMID 12942097 DOI: 10.1038/Sj.Bmt.1704165 |
0.453 |
|
| 2003 |
Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, Weissman IL. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proceedings of the National Academy of Sciences of the United States of America. 100: 10002-7. PMID 12890867 DOI: 10.1073/Pnas.1633833100 |
0.791 |
|
| 2003 |
Iwasaki-Arai J, Iwasaki H, Miyamoto T, Watanabe S, Akashi K. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. The Journal of Experimental Medicine. 197: 1311-22. PMID 12756267 DOI: 10.1084/Jem.20021843 |
0.388 |
|
| 2003 |
Terskikh AV, Miyamoto T, Chang C, Diatchenko L, Weissman IL. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood. 102: 94-101. PMID 12623852 DOI: 10.1182/Blood-2002-08-2509 |
0.506 |
|
| 2003 |
Nakorn TN, Miyamoto T, Weissman IL. Characterization of mouse clonogenic megakaryocyte progenitors. Proceedings of the National Academy of Sciences of the United States of America. 100: 205-10. PMID 12490656 DOI: 10.1073/Pnas.262655099 |
0.512 |
|
| 2002 |
Manz MG, Miyamoto T, Akashi K, Weissman IL. Prospective isolation of human clonogenic common myeloid progenitors. Proceedings of the National Academy of Sciences of the United States of America. 99: 11872-7. PMID 12193648 DOI: 10.1073/Pnas.172384399 |
0.538 |
|
| 2002 |
Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, Weissman IL, Akashi K. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Developmental Cell. 3: 137-47. PMID 12110174 DOI: 10.1016/S1534-5807(02)00201-0 |
0.481 |
|
| 2001 |
Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ, Burel SA, Lagasse E, Weissman IL, Akashi K, Zhang DE. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proceedings of the National Academy of Sciences of the United States of America. 98: 10398-403. PMID 11526243 DOI: 10.1073/Pnas.171321298 |
0.687 |
|
| 2001 |
Traver D, Miyamoto T, Christensen J, Iwasaki-Arai J, Akashi K, Weissman IL. Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets. Blood. 98: 627-35. PMID 11468160 DOI: 10.1182/Blood.V98.3.627 |
0.792 |
|
| 2001 |
Manz MG, Traver D, Akashi K, Merad M, Miyamoto T, Engleman EG, Weissman IL. Dendritic cell development from common myeloid progenitors. Annals of the New York Academy of Sciences. 938: 167-73; discussion 1. PMID 11458504 DOI: 10.1111/J.1749-6632.2001.Tb03586.X |
0.691 |
|
| 2001 |
Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood. 97: 3333-41. PMID 11369621 DOI: 10.1182/Blood.V97.11.3333 |
0.637 |
|
| 2001 |
Mebius RE, Miyamoto T, Christensen J, Domen J, Cupedo T, Weissman IL, Akashi K. The fetal liver counterpart of adult common lymphoid progenitors gives rise to all lymphoid lineages, CD45+CD4+CD3- cells, as well as macrophages. Journal of Immunology (Baltimore, Md. : 1950). 166: 6593-601. PMID 11359812 DOI: 10.4049/Jimmunol.166.11.6593 |
0.744 |
|
| 2000 |
Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, Weissman IL. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science (New York, N.Y.). 290: 2152-4. PMID 11118150 DOI: 10.1126/Science.290.5499.2152 |
0.695 |
|
| 2000 |
Takenaka K, Harada M, Fujisaki T, Nagafuji K, Mizuno S, Miyamoto T, Otsuka T, Gondo H, Okamura T, Niho Y. Human thymic epithelial cells maintain long-term survival of clonogenic myeloid and erythroid progenitor cells in vitro. British Journal of Haematology. 111: 363-70. PMID 11091226 DOI: 10.1046/J.1365-2141.2000.02337.X |
0.38 |
|
| 2000 |
Kondo M, Scherer DC, Miyamoto T, King AG, Akashi K, Sugamura K, Weissman IL. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 407: 383-6. PMID 11014194 DOI: 10.1038/35030112 |
0.672 |
|
| 2000 |
Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proceedings of the National Academy of Sciences of the United States of America. 97: 7521-6. PMID 10861016 DOI: 10.1073/Pnas.97.13.7521 |
0.574 |
|
| 2000 |
Akashi K, Richie LI, Miyamoto T, Carr WH, Weissman IL. B lymphopoiesis in the thymus. Journal of Immunology (Baltimore, Md. : 1950). 164: 5221-6. PMID 10799882 DOI: 10.4049/Jimmunol.164.10.5221 |
0.486 |
|
| 2000 |
Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404: 193-7. PMID 10724173 DOI: 10.1038/35004599 |
0.696 |
|
| 2000 |
Tokunaga Y, Miyamoto T, Gondo H, Okamura T, Niho Y. Effect of thrombopoietin on acute myelogenous leukemia blasts. Leukemia & Lymphoma. 37: 27-37. PMID 10721767 DOI: 10.3109/10428190009057626 |
0.403 |
|
| 2000 |
Takenaka K, Harada M, Fujisaki T, Nagafuji K, Mizuno S, Miyamoto T, Otsuka T, Gondo H, Okamura T, Niho Y. Human thymic epithelial cells maintain long-term survival of clonogenic myeloid and erythroid progenitor cells in vitro British Journal of Haematology. 111: 363-370. DOI: 10.1111/J.1365-2141.2000.02337.X |
0.368 |
|
| 1999 |
Katayama Y, Mahmut N, Takimoto H, Maeda Y, Yano T, Kojima K, Azuma T, Hara M, Imajyo K, Takahashi S, Kai T, Ohno Y, Miyamoto T, Nagafuji K, Matsue K, et al. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period. Bone Marrow Transplantation. 23: 659-65. PMID 10218841 DOI: 10.1038/Sj.Bmt.1701638 |
0.457 |
|
| 1999 |
Mizuno SI, Akashi K, Ohshima K, Iwasaki H, Miyamoto T, Uchida N, Shibuya T, Harada M, Kikuchi M, Niho Y. Interferon-γ Prevents Apoptosis in Epstein-Barr Virus-Infected Natural Killer Cell Leukemia in an Autocrine Fashion Blood. 93: 3494-3504. DOI: 10.1182/Blood.V93.10.3494.410K14_3494_3504 |
0.35 |
|
| 1998 |
Tokunaga Y, Miyamoto T, Okamura T, Eto T, Gondo H, Kamimura T, Okamura S, Niho Y. Effect of thrombopoietin on proliferation of blasts from CD7‐positive acute myelogenous leukaemia British Journal of Haematology. 102: 1232-1240. PMID 9753051 DOI: 10.1046/J.1365-2141.1998.00915.X |
0.331 |
|
| 1998 |
Takamatsu Y, Miyamoto T, Iwasaki H, Makino S, Tamura K. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature. Acta Haematologica. 99: 224-30. PMID 9644302 DOI: 10.1159/000040844 |
0.333 |
|
| 1998 |
Miyamoto T, Gondo H, Miyoshi Y, Shigematsu H, Minematsu T, Takenaka K, Tanimoto K, Horiuchi T, Asano Y, Inaba S, Minamishima Y, Niho Y. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma British Journal of Haematology. 100: 348-350. PMID 9488625 DOI: 10.1046/J.1365-2141.1998.00572.X |
0.466 |
|
| 1998 |
Gondo H, Harada M, Miyamoto T, Takenaka K, Tanimoto K, Mizuno S, Fujisaki T, Nagafuji K, Hayashi S, Eto T, Taniguchi S, Akashi K, Harada N, Yamasaki K, Shibuya T, et al. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transplantation. 20: 821-6. PMID 9404921 DOI: 10.1038/Sj.Bmt.1700979 |
0.489 |
|
| 1997 |
Fukumoto Y, Miyamoto T, Okamura T, Gondo H, Iwasaki H, Horiuchi T, Yoshizawa S, Inaba S, Harada M, Niho Y. Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. British Journal of Haematology. 97: 666-8. PMID 9207419 DOI: 10.1046/J.1365-2141.1997.842724.X |
0.442 |
|
| 1997 |
Miyamoto T, Nagafuji K, Harada M, Niho Y. Significance of Quantitative Analysis of AML1/ETO Transcripts in Peripheral Blood Stem Cells from t(8;21) Acute Myelogenous Leukemia Leukemia & Lymphoma. 25: 69-75. PMID 9130615 DOI: 10.3109/10428199709042497 |
0.495 |
|
| 1997 |
Miyamoto T, Akashi K, Hayashi S, Oogami A, Okamura T, Iwasaki H, Murakawa M, Harada M, Niho Y. Pericentric inversion of chromosome 16 and eosinophilia in chronic myelomonocytic leukemia Cancer Genetics and Cytogenetics. 94: 99-102. PMID 9109936 DOI: 10.1016/S0165-4608(96)00207-5 |
0.326 |
|
| 1997 |
Katayama Y, Yano T, Bessho A, Deguchi S, Sunami K, Mahmut N, Shinagawa K, Omoto E, Makino S, Miyamoto T, Mizuno S, Fukuda T, Eto T, Fujisaki T, Ohno Y, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplantation. 19: 283-287. PMID 9028559 DOI: 10.1038/Sj.Bmt.1700644 |
0.344 |
|
| 1997 |
Takenaka K, Gondo H, Tanimoto K, Nagafuji K, Fujisaki T, Mizuno S, Miyamoto T, Okamura T, Hayashi S, Eto T, Osaki K, Yamasaki K, Shibuya T, Harada N, Teshima T, et al. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group. Bone Marrow Transplantation. 19: 241-8. PMID 9028553 DOI: 10.1038/Sj.Bmt.1700637 |
0.422 |
|
| 1997 |
Teshima T, Sunami K, Bessho A, Shinagawa K, Omoto E, Ueoka H, Harada M, Ohno Y, Miyoshi T, Miyamoto T, Higuchi M. Circulating Immature Cell Counts on the Harvest Day Predict the Yields of CD34+ Cells Collected After Granulocyte Colony-Stimulating Factor Plus Chemotherapy-Induced Mobilization of Peripheral Blood Stem Cell Blood. 89: 4660-4660. DOI: 10.1182/Blood.V89.12.4660 |
0.495 |
|
| 1996 |
Harada M, Teshima T, Fujisaki T, Mizuno S, Miyamoto T, Takamatsu Y, Kubota A, Ohno Y, Kuroiwa M, Takenaka K, Eto T, Akashi K, Gondo H, Okamura T, Inaba S, et al. Granulocyte colony-stimulating factor-induced mobilization of peripheral blood stem cells for autologous and allogeneic transplantation. Fukuoka Bone Marrow Transplantation Group. Cancer Chemotherapy and Pharmacology. S115-9. PMID 8765430 DOI: 10.1007/S002800051051 |
0.422 |
|
| 1996 |
Harada M, Nagafuji K, Fujisaki T, Kubota A, Mizuno S, Takenaka K, Miyamoto T, Ohno Y, Gondo H, Kuroiwa M, Okamura T, Inaba S, Niho Y. G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation. Journal of Hematotherapy. 5: 63-71. PMID 8646483 DOI: 10.1089/Scd.1.1996.5.63 |
0.445 |
|
| 1996 |
Takenaka K, Mizuno SI, Harada M, Nagafuji K, Miyamoto T, Iwasaki H, Fujisaki T, Kubota A, Ohno Y, Arima F, Shigematsu H, Gondo H, Okamura T, Okamura S, Inaba S, et al. Generation of human natural killer cells from peripheral blood CD34+ cells mobilized by granulocyte colony-stimulating factor. British Journal of Haematology. 92: 788-94. PMID 8616068 DOI: 10.1046/J.1365-2141.1996.408950.X |
0.372 |
|
| 1996 |
Takenaka K, Nagafuji K, Harada M, Mizuno S, Miyamoto T, Makino S, Gondo H, Okamura T, Niho Y. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95) Blood. 88: 2871-2877. DOI: 10.1182/Blood.V88.8.2871.Bloodjournal8882871 |
0.378 |
|
| 1996 |
Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T, Takenaka K, Mizuno S, Gondo H, Okamura T, Dohy H, Niho Y. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia Blood. 87: 4789-4796. DOI: 10.1182/Blood.V87.11.4789.Bloodjournal87114789 |
0.464 |
|
| 1995 |
Miyamoto T, Nagafuji K, Harada M, Eto T, Fujisaki T, Kubota A, Akashi K, Mizuno S, Takenaka K, Kanaji T. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia. British Journal of Haematology. 91: 132-8. PMID 7577620 DOI: 10.1111/J.1365-2141.1995.Tb05258.X |
0.477 |
|
| 1995 |
Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells Blood. 86: 883-889. DOI: 10.1182/Blood.V86.3.883.Bloodjournal863883 |
0.351 |
|
| Show low-probability matches. |